Loyola University Chicago

Loyola eCommons
Dissertations

Theses and Dissertations

1978

The Interaction of Thioxanthenones with Nucleic Acids
Laszlo Bodoni
Loyola University Chicago

Follow this and additional works at: https://ecommons.luc.edu/luc_diss
Part of the Biochemistry, Biophysics, and Structural Biology Commons

Recommended Citation
Bodoni, Laszlo, "The Interaction of Thioxanthenones with Nucleic Acids" (1978). Dissertations. 1722.
https://ecommons.luc.edu/luc_diss/1722

This Dissertation is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons.
It has been accepted for inclusion in Dissertations by an authorized administrator of Loyola eCommons. For more
information, please contact ecommons@luc.edu.
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Copyright © 1978 Laszlo Bodoni

THE INTERACTION OF
THIOXANTHENONES WITH
NUCLEIC ACIDS

by
Laszlo Bodoni

A Dissertation
Submitted to the Faculty of the Graduate School
of Loyola University of Chicago in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Philosophy

May

1978

ACKNOlofl.EDGEMENTS
The author would like to thank his advisor, Dr. Stelios Aktipis"'
for the encouragement and advice that he provided during the course of
this work.
Thanks are due to Drs. Allen Frankfater and Norten Melchior for
many hours of helpful discussion.
Also many thanks to Antonis Kindelis, Kenneth Micetich, and
Robert Wersto for their helpful criticism.

ii

VITA
The author, Laszlo Bodoni, is the son of Laszlo Bodoni and
Margit (Renter) Bodoni.

He was born August 14, 1939, in Szeged,

Hungary.
His elementary education was obtained in the public schools
of Szeged, Hungary, and secondary education at the Radnoti Miklos
High School, Szeged, Hungary, where he graduated in 1957.
In September, 1958, he entered the University of Szeged, and
in June 1963, received a Diploma with a major in physical chemistry.
He joined the Department of Biochemistry and Biophysics of
Loyola University of Chicago in the fall of 1971.

iii

TABLE OF CONTENTS
Page
ii

ACKNOWLEDGEMENTS •
VITA • . • • •

iii

LIST OF TABLES •

vii
viii

LIST OF ILLUSTRATIONS
Chapter
I.

INTRODUCTION

1

1.
2.

1

3.
4.
5.
6.

7.
8.
II.

The Structure of Thioxanthenone
• • • •
The Structure and Physicochemical Properties of
Thioxanthenone Derivatives
• • • • • • •
Schistosomicidal Activity of Thioxanthenones
Carcinostatic Activity of Thioxanthenones • •
Bacteriostatic Activity of Thioxanthenones • • • • •
The Interaction of Thioxanthenones with Nucleic Acids
1. Physicochemical Evidence for the Interaction of
Thioxanthenones with Nucleic Acids • • • • • • •
2. The Intercalation of Thioxanthenones with Nucleic Acids • . • • • • • • • • • • • • • • • •
3. The Effect of the Intercalation between Thioxanthenones and Nucleic Acids on RNA Synthesis •
Circular Dichroism of Drug-DNA Complexes
1. Circular Dichroism Definitions • • • • • • • • •
2. Optical Activity of Drug-DNA Complexes •
The Scope of This Investigation

MATERIALS AND METHODS •
1.
2.
3.

4.
5.
6.

7.
8.

6

14
17
22
23

23
24
27

31
31
32

34

36

Materials • • •
Instruments • •
Purification of Miracil D
• •
Preparation of Deoxyribonucleic Acid from Bacterio-

36
37

phage T2

39
40
42
42

• .

. • .

. . • . . • • • • . • • • ,•

Preparation of Stock and Working Solutions • • • • •
Preparation of Drug-DNA Complexes •
• • • •
Dimerization Studies • • • • • • • • • • •
Binding Studies • . • • • • . . • • • • • •
1. The Analysis of the Spectra of Drug-Nucleic Acid
Complexes
. . . . • • . . . • • . . .
iv

38

45
45

Page
2.

9.
10.

11.
III.

The Determination of the Absorption of Bound
Drug • • • • • • . • • • • • • • • • •
3. Scatchard Plots and Their Interpretation •
Circular Dichroism Measurements • • • • • • •
Measurements at Elevated Temperatures • • •
1. Definitions, Terminology, and Formulas Used i~
Hyperchromicity Measurements • • •
• • • • •
2. Instrumentation • • • • • • • • •
• • • • •
3. Determination of the Dependence of Association
Constants on Temperature . • • • •
• • • • •
4. Measurements of the Circular Dichroism of DrugDNA Complexes at Elevated Temperatures •
RNA Polymerase Assays

EXPERIMENTAL RESULTS
1.
2.

3.

4.

5.

47
48
49
51
51

55
56
58
59
64

Dimerization Studies
Binding Studies . • •
. • • • • •
1. The Binding of Mir ac il D to Calf Thymus DNA at
0.01 and 0.2 M Salt Concentrations • • • • •
2. The Binding of Miracil D to Calf Thymus DNA
under RNA Polymerase Assay Conditions
3. The Dependence of the Binding of Miracil D to
Calf Thymus DNA on Temperature • • • • • • • • •
4. The Binding of Methyl-Miracil D to Calf Thymus
DNA at 0.01 M Salt Concentration •
5. The Binding ;f MDMT to Calf Thymus DNA •
Circular Dichroism Measurements • • • • • • • • •
1. The Miracil D-DNA Complex ·
• • • • • •
2. The Methyl-Miracil D-DNA Complex
3. The MDMT-DNA Complex • • • • • • ••
Hyperchromicity and Circular Dichroism Measurements
at Elevated Temperatures . • • • •
• • • • • •
1. Hyperchromicity of the Miracil D-DNA and MethylMiracil D-DNA Complexes • • • • • • • • • •
2. Circular Dichroism Measurements at Elevated
Temperatures
• • • • • • • • • • • • •
1. Miracil D-DNA Complex at Low Binding Ratios
2. Miracil D-DNA Complex at High Binding
Ratios
3. Stabilization of the DNA Helix by Miracil D and
Methyl-Miracil D • . • . • • • • • • • • • • • •
The Inhibition of RNA Synthesis by Thioxanthenones
1. The RNA Synthesis Assay at pH 7.0 • • • • • • •
2. The Inhibition of RNA Polymerase by Miracil D,
Methyl-Miracil D, and MD~IT • • • • • • • •
3. Comparison of the Effectiveness of Miracil D and
Methyl-Miracil D to Inhibit RNA Synthesis
v

64

69
69
82
82

85
94

95
95
104
107
107
107
125
126
129
133
137
137
140
147

Page
4.
IV.

149

DISCUSSION

158

1.
2.
3.
4.

158
159
163

5.

6.
V.

Miracil D: An Inhibitor of RNA Chain Initiation
and Elongation .

The Structure of the Miracil D-DNA Complex • • • • •
The Binding of Miracil D to DNA - The Exclusion Model
The Structure of the Methyl-Miracil D-DNA Complex •
The Circular Dichroism of Miracil D-DNA and MethylMiracil D-DNA Complexes • • • • • • • • • • • • • • •
The Inhibition of RNA Synthesis by Miracil D and
Methyl-Miracil D • • • • • • • • • • • • • • • •
1. The Inhibition of Initiation of RNA Synthesis
by Miracil D and Methyl-Miracil D • • • • • • •
2. The Inhibition of Elongation of RNA Synthesis
by Miracil D and Methyl-Miracil D • • • • • • •
Considerations on the Association and Dissociation
Rates of Miracil D, Methyl-Miracil D, and MDMT

164
167
167
172
174
179

SUMMARY •

BIBLIOGRAPHY .

182

APPENDIX A

189

.....

APPENDIX B •

194
199

APPENDIX C •

vi

LIST OF TABLES
Page

Table
I.

The effect of Miracil D and methyl-Miracil D on the melting
temperature of calf thymus DNA in 0.01 M sodium acetate
buffer, pH 5 .. 0 . . . . . . . . . . . . . . . . . . . . . . .

II.

119

The extent of thermal stabilization of calf thymus DNA by
Miracil D and methyl-Miracil D in 0.01 M sodium acetate
buffer, pH 5.0 and the binding ratios of Miracil D-DNA and
methyl-Miracil D-DNA complexes at the melting temperatures
(at 260 nm)

. . . . . . • . . • • . . . . . . . . .. • . . .

vii

134

LIST OF ILLUSTRATIONS
Page

Figure
1.
2.
3.

4.
Sa.
5b.
6.
7.
8.
9.

10.
11.

The structural formula of thioxanthenone •
Resonance structures for thioxanthenone
The structural formula of 10-thioxanthene
The structural formula of Miracil D
The structural formula of methyl-Miracil D
The structural formula of MDMT • • • • •
The structural formula of Hycanthone • • •
The structure of the Miracil D-poly A•poly U complex •
Typical dependence of hyperchromicity h on the temperature
of nucleic acids and drug-nucleic acid complexes • • •
The absorption spectrum of Miracil D in 0.01 M sodium
acetate buffer, pH 5.0 at room temperature • • • . • •
The dependence of the root-mean-square deviation on the
dimerization constant Kd of Miracil D at room temperature
The dependence of the apparent extinction coefficient Ea
on the fraction a of Miracil D present as monomer at var~gus
wavelengths

. . . . . . . . . . . . . . . . . . . . . . . .

12.

The absorption spectra of Miracil D-DNA complexes in 0.01 M
sodium acetate buffer, pH 5.0 at room temperature obtained

13.

A plot of reciprocal differential absorbance 1/(Af-A) versus
reciprocal DNA concentration • • • • • • • • • • • • • • • •
The Scatchard plot of the binding of Miracil D to calf
thymus DNA in 0.01 M sodium acetate buffer, pH 5.0 at room

in 5 em cells

14.

. . . . . . . . . . . . . . . . . . . . . . .

temperature . . . . . . . . . . . . . . . . . . . . . . . . .

15.

'

17.
18.

19.
20.

4
7
9

12
15
18
28

52

65
67

70
72

75
77

The Scatchard plot of the binding of Miracil D to calf
thymus DNA in 0.2 M sodium acetate buffer, pH 5.0 at room
temperature

16.

2

-

• . . . .

. . . . . . . . • . . . . • . .

The Scatchard plot of the binding of Miracil D to calf
thymus DNA under RNA polymerase assay conditions at 37 °C
The van't Hoff plot of Miracil D-DNA binding in 0.01 M sodium acetate buffer, pH 5.0 • • • • • • • • • • • . • • •
The absorption spectra of methyl-Miracil D-DNA complexes in
0.01 M sodium acetate buffer, pH 5.0 at room temperature
obtained in 10 em cells • • • • • • • • • • • • • • • •
The Scatchard plot of the binding of methyl-Miracil D to
calf thymus DNA in 0.01 M sodium acetate buffer, pH 5.0 at
room temperature • • • • • • . . • . • . • • • • • . • • . •
The circular dichroism spectra of Miracil D-DNA complexes
in 0.01 M sodium acetate buffer, pH 5.0 at room temperature
in 10 em-cells . . . . . . . . . . . . . . . . . . . . . . .

viii

80
83

86

88

91
96

Figure

21.

22.

23.

24.
25.

26.

27.

28.

29.

30.

31.

Page

The dependence of the differential molar extinction coefficient EL-ER of Miracil D-DNA complexes at 337 nm on the
binding ratio r in 0.01 ~sodium acetate buffer, pH 5.0
at room temperature • • • • • . • • • • • • • • • • • • •
The dependence of the differential molar extinction coefficient EL-ER of Miracil D-DNA complexes at 347 nm on the
binding ratio r in 0.01 M sodium acetate buffer, pH 5.0
at room temperature • • • • • • • . • • . • • • • • • • •
The dependence of the differential molar extinction coefficient EL-ER of Miracil D-DNA complexes at 447 nm on the
binding ratio r in 0.01 M sodium acetate buffer, pH 5.0
at room temperature • • • • • • • • • • • • • • • • • •
The circular dichroism spectra of methyl-Miracil D-DNA
complexes in 0.01 M sodium acetate buffer, pH 5.0 at
room temperature in 10 em cells • • • • • • • • • • • •
The dependence of the differential molar extinction coefficient ~-ER of methyl-Miracil D-DNA complexes at 335 nm
on the binding ratio r in 0.01 M sodium acetate buffer,
pH 5.0 at room temperature •• -. • • • • • • • • • • • •
The dependence of the differential molar extinction coefficient EL-ER of methyl-Miracil D-DNA complexes at 353 nm
on the binding ratio r in 0.01 M sodium acetate buffer,
pH 5.0 at room temperature • • • • • • . • • • • • • • •
The dependence of the differential molar extinction coefficient EL-ER of methyl-Miracil D-DNA complexes at 405 nm
on the binding ratio r in 0.01 M sodium acetate buffer,
pH 5.0 at room temperature • • • • • • • • • • • • • •
The dependence of the normalized hyperchromicity h of
0
calf thymus DNA and Miracil D-calf thymus DNA complexes
at 260 nm on the temperature in 0.01 M sodium acetate
buffer, pH 5.0 in 1 em cell. • . • • • . • • • • • •
The dependece of the normalized hyperchromicity hu of
calf thymus DNA and methyl-Miracil D-calf thymus DNA
complexes at 260 nm on the temperature in 0.01 M sodium
acetate buffer, pH 5.0 and 1 em cell • • • • • -. • • •
The dependence of the normalized absorbance change ~A of
Miracil D-calf thymus DNA complexes at 440 nm on the n
temperature in 0.01 M sodium acetate buffer, pH 5.0 and
1 em cell . . . . . . . . . . . . . . . . . . . . . . . .
The dependence of the normalized absorbance change ~n of
methyl-Miracil D-calf thymus DNA complexes at 440 nm on
the temperature in 0.01 ~1 sodium acetate buffer, pH 5.0
and 1 em cell . • • • • : • . • • • • • • . • • • • • •

ix

•

98

•

100

102
105

•

108

•

110

·112

115

117

.

121

123

Page

Figure
32.

35.
36.

The dependence of the normalized absorbance change AAn at
440 nm, the differential molar extinction coefficient
EL-ER at 347 nm, and the differential molar extinction
coefficient EL-ER corrected for conformational changes
at 347 nm on the temperature of Miracil D-calf thymus DNA
complex in 0.01 M sodium acetate buffer, pH 5.0 and 1 em
cel.l . . . . . . . . . . . . . . . . . . . . . . . . . . . .
The dependence of the normalized absorbance change AAn at
440 nm and the differential molar extinction coefficient
EL-ER on the temperature of Miracil D-calf thymus DNA
complex in 0.01 M sodium acetate buffer, pH 5.0 and 1 em
cell . . . . . . . . . . . . . . . . . . . . . .. . . . .
The effectiveness of Miracil D and methyl-Miracil D in
stabilizing calf thymus DNA against heat denaturation in
0.01 M sodium acetate buffer, pH 5.0 • • • • • • • • • •
The kinetics of RNA synthesis
• • • • • • • • • •
The dependence of RNA synthesis on the template concen-

37.
38.

The inhibition of RNA synthesis by Miracil D
• • • • •
The inhibition of RNA synthesis by methyl-Miracil D and

33.

34.

tration

. . . . . . . . . . . . . . . . . . . . .

MDMT • • • • • . • • • • • • • . • • • • . • • • • • • •

39.
40.
41.
42.
43.

The inhibition of RNA synthesis by Miracil D and methylMiracil D as the function of the binding ratio r • •
The dependence of the reciprocal initial velocity of RNA
synthesis on the binding ratio r in the presence of
Miracil D and methyl-Miracil D • • • • • • • • • • • • • • •
The dependence of the reciprocal initial velocity and of
the initiation of RNA synthesis on the binding ratio r in
the presence of Miracil D
• • • • • • • • • • • •
A dimer structure proposed for Miracil D in aquaeous
solutions • • • • • • • • • • • • • • • • • • • • • • • • •
Schematic representation of the f(r) polynomial for
different values of 8 as parameter • . • • • • • • • •

X

127

131

135
138
141
143
145

150
153
155
191
203

CHAPTER I
INTRODUCTION
A number of thioxanthenone derivatives are known to possess
schistosomicidal, carcinostatic, and bacteriostatic activities.
Miracil D, as one of the most potent thioxanthenones, and its congeners
have been the subject of intense investigations for nearly three
decades.

The majority of the investigations have been concerned

mainly with the biological effects of these compounds.
action at the molecular level is not understood yet.

Their mode of
This dissertation

represents an effort to correlate some of the physicochemical and biological properties of two thioxanthenones (see section I.8).
I.1.

The Structure of Thioxanthenone
Thioxanthenone (Figure 1) has a permanent electric dipole moment

of 2.59 Debeyes in benzene at 25

0

C (Aroney et al., 1971).

Assuming the

participation of the d-orbitals of the sulfur atom in the formation of
molecular orbitals, the bond order of the carbonyl C=O bond is calculated to be close to that of a carbon-carbon bond of benzene (Given et
al., 1965).

These findings suggest that the thioxanthenone molecule is

best desc.ribed by the resonance structures shown in Figure 2.

This de-

localization of electrons leads to a charge distribution with permanent
electric dipole moment, the vector of which is located along the C9-S10
axis.

In addition, the possibility that a conjugated double bond

system forms over the three rings lends credibility to a planar threering structure.

Although this possibility was doubted lately (Aizen1

2

Figure 1.
9-one).

The structural formula of thioxanthenone (10-thioxanthene-

3

4

Figure 2.

Resonance structures for thioxanthenone.

5

101

I

-

(X))
-+

6

shtat et al., 1972), no good evidence exists to suggest that the thioxanthenone ring is not planar.
The importance of the exocyclic oxygen atom in maintaining the
planar ring structure can be demonstrated by the comparison of the thioxanthenone and thioxanthene (Figure 3) system.

Thioxanthene is also a

polar molecule, but based on the measurement of dipole moments it has
been concluded that the molecule is definitely not planar (Aroney et
~·

1969).

In fact, the dihedral angle determined by the planes of the

two benzene rings is calculated to be 135 ° in carbon tetracholride and
160 ° in benzene.

NMR measurements have provided evidence that the

molecule rapidly inverts between the two possible dihedral conformations
(Aizenshtat et al., 1972).
I.2.

The Structure and Physicochemical Properties of Thioxanthenone

Derivatives
Miracil D (Kikuth et al., 1946) is the trade name (Bayer) for
1-(4-ethyl-1,4-diazahexyl)-4-methyl-10-thioxanthene-9-one (Figure 4).
It is also marketed under the trade names Nilodin (Burroughs Wellcome)
and Lucanthone (Calbiochem).

This crystalline yellow solid has a mole-

cular weight of 376.7 daltons (as monohydrochloride) and is soluble in
water up to 1-2% (Blair, 1958; Hawking and Ross, 1948).
decrease its solubility (Lea et al., 1972).

Salts

Its melting point varies

between 195 and 197 °C according to different authors (Blanz and
French, 1963; Mauss, 1948; Sharp, 1951).

Infrared spectroscopy studies

suggest that in the solid phase the distal nitrogen atom in Miracil D
monohydrochloride is protonated (Zilversmit, 1970).
In aquaeous solution both nitrogen atoms of Miracil D partici-

7

Figure 3.

The structural formula of 10-thioxanthene.

8

9

Figure 4.

The structural formula of Miracil D (1-(4-ethyl-1,4-di-

azahexyl)-4-methyl-10-thioxanthene-9-one).

10

0

II

(XI

C
9

10

s

CH3

11
pate in acid-base equilibria.

The pKa of the proximal nitrogen atom

was determined spectrophotometrically and found to be -0.20 (Zilversmit, 1970).

Since the free base is not soluble in water, the pKa of

the distal nitrogen atom was determined from titration curves
nol-water mixtures (Munro, 1961).

in etha-

Extrapolation to pure water gave a

pKa of 7.4.
On the basis of electronic and vibrational spectral studies,
Zilversmit found that the hydrogen atom on the proximal nitrogen atom
forms an intramolecular hydrogen bond with the carbonyl oxygen of
Miracil D, and the trigonal proximal nitrogen atom is coplanar with the
heterocyclic ring system (Zilversmit, 1971).
The tendency of Miracil D to form aggregates in aquaeous solutions was noted in the work of Scholtan (Scholtan, 1959).

In this

study, sedimentation and diffusion coefficient measurements were combined to assess the degree of aggregation.

However, the conditions

used for these studies were not carefully defined and the validity of
the quantitative findings is open to some question.
Methyl substitution on the proximal nitrogen atom of Miracil D
leads to a conformational change in the molecular structure.

The

structure of methyl-Miracil D (Figure 5a) does not permit the formation
of an intramolecular hydrogen bond.

The steric interference between

the methyl group and the oxygen atom of the carbonyl group necessitates
a rotation of the amine side chain on the C1-proximal nitrogen atom
bond axis to permit these substituents to achieve their Van der Waals
separation (Zilversmit, 1970).

As a result of this rotation, the

conjugation of the lone electron pair of the proximal nitrogen atom to

12

Figure 5a.

The structural formula of methyl-Miracil D (1-(4-ethyl-

1-methyl-1,4-diazahexyl)-4-methyl-10-thioxanthene-9-one).

13

CH3

14
the aromatic ring system is reduced, and the electron density of the
nitrogen atom is increased.

The pKa of the proximal nitrogen atom is

3 .41 contrasted with a corresponding value of -0.20 for Miracil D.
MDMT (1-(4-methyl-1,4-diazapentyl)-4-methyl-10-thioxanthene)
(Figure 5b), although not a thioxanthenone, will also be considered in
this investigation.

The MDMT molecule contains the 10-thioxanthene

ring structure (Figure 3), and, therefore, the MDMT molecule is not
planar but rather the molecule rapidly inverts between the two possible
dihedral conformations (see section 1.1).

The purpose of this selection

is to examine the effect of ring puckering on the intercalation process
(see section 1.6.2) and on the inhibiton of DNA dependent RNA synthesis.
!.3.

Schistosomicidal Activity of Thioxanthenones
Schistosomes (Class Trematoda, Genus Schistosoma) are parasites

which pass through a number of stages in their development.
species of animals serve as hosts.

Several

In the disease schistosomiasis

(also called bilharziasis), schistosomes penetrate the blood vessels of
the urinary bladder, intestines, liver, and spleen of their hosts.
Certain snails, in which the schistosomes spend one of their life
cycles, act as intermediate hosts in the transmission of the disease.
A particular segment of human populations, mostly in tropical
countries, is infected by the species S. mansoni (South America),
S. haematobium (Egypt), and S. japonicum (Philippines).
The discovery of the family of Miracils emerged from the worldwide need for the treatment of schistosomiasis.

Miracil D proved to be

the most potent member of the family against S. mansoni infections in

15

Figure Sb.

The structural formula of MDMT (1-{4-methyl-1,4-diaza-

pentyl)-4-methyl-10-thioxanthene).

16

CH3

17
mice and monkies as judged from the decrease of egg secretion in feces
(Kikuth et al., 1946).

Autopsy revealed that upon treating with the

drug, the mature schistosomes lose their motility, decrease in size,
and become fragile (Kikuth and G8nnert, 1948).
drug attack are the sex- and yolk-cells.
succesful in humans (Blair, 1958).

The chief points of

Clinical trials were also

Investigations on the structure-ac-

tivity relationship of thioxanthenones showed that activity depends on
the genus of the host, even when the same strain of the parasite is
used for infection (GBnnert, 1961).

However, an absolute requirement

for the 4-methyl group of Miracil D is present.
The host-dependent structure-activity relationship engendered
metabolic studies of Miracil D in different species to examine the
possibility that the drug was converted to an active agent in vivo.
In mammalian organisms, there are three major metabolic pathways for
Miracil D: hydroxylation of the 4-methyl group, desethylation of the
terminal side chain nitrogen, and sulfoxidation (Rosi et al., 1967).
The first of these appears crucial for the in vivo activation of
l1iracil D, since the hydroxylated derivative, Hycanthone (Figure 6), is
significantly more active than the parent compound.

This clarifies

the absolute requirement for the 4-methyl group mentioned earlier.
Recently it was found that Hycanthone is an inhibitor of acetylcholine receptors of the nervous system in S. mansoni (Hillman and
Gibler, 1975).
1.4.

Carcinostatic Activity of Thioxanthenones
In early experiments, Miracil D was found effective in retarding

the growth of the Walker rat carcinoma, less effective against a benzo-

18

Figure 6.

The structural formula of Hycanthone (1-(4-ethyl-1,4-di-

azahexyl)-4-hydroxymethyl-10-thioxanthene-9-one).

19

20
pyrene induced rat sarcoma, and entirely inactive against the solid
form of the Ehrlich carcinoma in mice (Hackman et al., 1949).
In a subsequent more extensive study,

~tlracil

D was found to

exhibit a wide spectrum of carcinostatic activity against a variety of
transplantable mouse tumors at non-toxic dosage levels (Hirschberg et
~'

1959).

Sarcoma 180 and lymphoid leukemia Ll210 ascites respond

most readily, followed by Adenocarcinoma 755 and E0771.

Glioma 26 and

the Ehrlich ascites carcinoma show a marginal response at best.

Seven-

teen other thioxanthenones have been compared to Miracil D in terms of
cytotoxicity in tissue cultures of human and mouse brain tumors, maximum tolerated dosage levels in the mouse, and carcinostatic activity
against a variety of mouse tumors.

None of the analogues approaches

the pronounced activity of Miracil D in vivo.

In tissue culture, how-

ever, many of the thioxanthenones are more active than the parent
compound.

No correlation was found between in vivo and in vitro car-

cinostatic activity, and schistosomicidal activity.
Studies, such as the above, were later extended to forty-four
thioxanthenone derivatives (Blanz and French, 1963).

As a result of

these investigations, the following generalities, regarding the
structures of the more effective antitumor derivatives, were formulated for leukemia L1210, Adenocarcinoma 755, and Sarcoma 180:
(a) the carbon chain between the nitrogen atoms of the side
chain of the thioxanthenone molecule must be two carbon atoms in length,
(b) the terminal alkyl group(s) must be small,
(c) the ring attached nitrogen atom must bear one hydrogen atom,
(d) there must be an unsubstituted sulfur atom in position 10,

21
(e) there must be a carbonyl group in position 9, and
(f) there must be a compact, fairly chemically stable substituent in position 4.
These structural characteristics lead to the speculation that the metal
chelating ability via the carbonyl group and the dialkylaminoethylamino chain may be essential for carcinostatic activity.
Subsequently it was established that the carcinostatic activity
of Miracil D against leukemia L1210 in mice was completely abolished by
the simultaneous administration of nontoxic doses of SKF 525-A (S-diethylaminoethyl diphenylpropylacetate hydrochloride) (Hirschberg et
al., 1964).

Since SKF 525-A inhibits microsomal enzyme systems which

catalyze a variety of metabolic transformations of drugs, this observation suggests that
tabolite before

~~racil

eL~ibiting

D is converted in vivo to an active me-

its carcinostatic activity.

In search of

the carcinostatic metabolite of Miracil D, Hirschberg and his coworkers
investigated the products formed in mammalian metabolism of Miracil D
(Hirschberg et al.t 1968).

None of the metabolites, including Hycan-

thone, proved superior to Uiracil D.

No correlation was found between

the schistosomicidal and the carcinostatic activities of these drugs.
Miracil D has been found to cause a concentration dependent inhibition of DNA and RNA synthesis in leukemia L1210 ascite cells of
mice (Wilson et al., 1972).

The drug inhibits DNA synthesis to a

greater extent than RNA synthesis in contrast to analogous findings in
bacteria.

Hethyl-Uiracil D was much less effective while Hycanthone

behaved similarly to

~:iracil

D

(~Ulson

et al., 1975).
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Bacteriostatic Activity of Thioxanthenones
Miracil D inhibits the growth of B. subtilis (Weinstein et al.,

1955), E. coli (Weinstein et al., 1967), S. typhimurium

(Hartman~

al., 1973), and the slime mold D. discoideum (Hirschberg et al., 1968).

-------

At the same time, Miracil D causes complete inhibition of total cellular RNA synthesis and partial inhibition of DNA and protein syntheses,

and blocks the induction of
~'

1967).

~-galactosidase

in E. coli (Weinstein et

In B. subtilis, the growth inhibition is accompanied by

the complete inhibition of RNA synthesis and the partial inhibition of
protein synthesis (Weinstein et al.,1955).

DNA synthesis is not in-

hibited in the first 20 minutes of an exponentially growing culture.
However, after 20 minutes DNA synthesis is also inhibited (Haidle et
al., 1970).

From transformation experiments using donor DNA from cells

grown in the presence of Miracil D, it was concluded that

in~

subtilis the drug permits the DNA molecules in the process of replication to complete the process, but prevents the reinitiation of
chromosome replication.

Although protein synthesis, using natural or

synthetic m-RNA, is not inhibited by the drug in subcellular systems
(Weinstein et al., 1967), the prevention of reinitiation of chromosome
replication is ascribed to the rapid inhibition of RNA synthesis .and
the subsequent inhibition of protein synthesis (Weinstein and Hirschberg, 1971).
The possibility that Miracil D affects the utilization of

~lA

precursors in vivo was excluded by investigating the inhibition of DNA .
dependent RNA polymerase of E. coli in vitro (Weinstein et al.,1967).
It was found indeed that the drug inhibits RNA polymerase in vitro.
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In addition, supplementation of the system with excess DNA reversed the
inhibition, whereas supplementation with excess enzyme did not, indieating that the target of drug action is the DNA and not the enzyme.
Methyl-Miracil D also inhibits the growth of B. subtilis, but
to a much lesser degree than Miracil D (Hirschberg et al., 1968).

In

contrast with the parent compound, methyl-Miracil D is reported not to
inhibit RNA synthesis in vitro.
1.6.
!.6.1.

The Interaction of Thioxanthenones with Nucleic Acids
Physicochemical Evidence for the Interaction of Thioxanthenones

with Nucleic Acids
Direct evidence for the interaction between Miracil D and nucleic
acids has been obtained from the spectrophotometric studies of Weinstein and his coworkers (Weinstein et al., 1965).

Miracil Din 0.33

~~

phosphate buffer, pH 6.8 exhibits absorption maxima at 330 and 442 nm.
Upon addition of calf thymus DNA, the maxima shift to longer wavelengths
and the absorbances decrease at the maxima.
50

~g/ml,

At a DNA concentration of

the maxima are shifted to 337 and 450 nm, respectively.

Qualitatively similar changes are produced by synthetic single stranded
ribonucleic acids.

However, some quantitative differences are noted

among nucleic acids when compared with respect to their ability to induce a shift in the absorption maximum of Miracil D from 330 to 337 nm.
At high polymer concentrations the order of relative effectiveness is:
DNA > poly A > poly U > poly C.

At lower polymer concentrations poly A

appeared to be the most effective in this respect.
Miracil D also has been found to stabilize native calf thymus DNA
from heat denaturation (Weinstein et al., 1965).

For example, in a
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buffer of low ionic strength and at a Miracil D concentration of
4 pg/ml, the melting temperature of DNA increases from 56 to 79

°c.

Methyl-Miracil D is much less effective in this respect (Hirschberg et
1968) .
a.,
1

-------

High ionic strength and addition of the tetramine spermine

seem to abolish the stabilizing effect.
Miracil D and Hycanthone cause an increase in the intrinsic

viscosity of native calf thymus DNA.

Methyl-Miracil D did not increase

the intrinsic viscosity of DNA under similar conditions (Carchman et
~'

1969).

The addition of spermine , as well as magnesium and sodium

ions reverses the effect of

~uracil

D and Hycanthone on DNA viscosity.

The significance of these data might be in some doubt in view of the
fact that the measurements were not carried out at constant drug-DNA
binding ratios.
I.6.2.

The Intercalation of Thioxanthenones with Nucleic Acids
In 1961 Lerman proposed a model for the interaction of acridines

with DNA (Lerman, 1961).

According to this model, the acridine mole-

cules, which possess planar heterocyclic ring systems, intercalate between adjacent base pairs in DNA.

The intercalation is accompanied by

an unwinding of the double helix, which, however, leaves the hydrogen
bonded base pairing intact.

This model is consistent with the X-ray

diffraction patterns of DNA-proflavine fibers, as well as the increase
in the intrinsic viscosity, and the decrease in the sedimentation
coefficient of DNA in the presence of acridines.
On the basis of the experimental findings presented in the preceding section, it was proposed that Miracil D intercalates forming a
complex, in which the thioxanthenone ring system is located between ad-

25
jacent DNA base pairs (Weinstein and Hirschberg, 1971).

In this

complex, the positively charged distal nitrogen atom of the side chain
interacts with the negatively charged phosphate residues of the DNA
backbone.
In the intercalated Miracil D-DNA complex, the Miracil D molecules should be oriented parallel to the base pairs and perpendicularly
to the long axis of DNA.

Indeed, flow dichroism studies have suggested

that the Miracil D chromophore is oriented perpendicularly to the long
axis of DNA, i.e. it is coplanar with the base pairs (private communications to Weinstein and Hirschberg, 1971).

This observation serves as

additional evidence that Miracil D interacts with DNA by intercalation.
The intercalation model for Miracil D has been further supported, though indirectly, by the sedimentation experiments of Waring
(Waring, 1970).

The replicative form (RF I) of bacteriophage

DNA consists of a covalently closed circular double helix.

~X

174

In addition

to the Watson-Crick type helical turns of the strands, the double helix
of the RF I form is folded into supercoils or superhelical structures.
Because of topological pecularities, characteristic of circularity,
this kind of DNA molecule displays large changes in supercoiling in
response to intercalation induced local unwinding of the helix.

Spe-

cifically, during the first phase of drug binding to superhelical DNA,
the number of right-handed supercoils, originally present in DNA, decreases.

At a certain level of binding, all supercoils are removed.

As further drug binding takes place, left-handed supercoils begin to
appear.

Since the supercoiled DNA molecules, no matter whether they

are left- or right-handed, are more compact than the DNA molecules with-

26
out supercoils, they sediment more rapidly.

Therefore, the loss or re-

appearance of supercoiling can be observed by monitoring changes in the
sedimentation coefficient.
The hydroxylated derivative of Miracil D, Hycanthone, exhibits
this characteristic property of intercalating drugs (such as ethidium
bromide, propidium iodide, proflavin, etc.) on the sedimentation coefficient of the closed circular duplex.

The intercalation of one Hycan-

thone molecule causes an unwinding of 16.4
angle of the helix*.

°

(corrected value) in the

Lately four indazole analogues of Miracil D and

Hycanthone were found to intercalate with DNA of bacteriophage PM2
(Waring, 1973).

Because of the relative insolubility of these ana-

logues, however, their binding to DNA has not been quantitated, and,
therefore, the author reports only lower limits of the unwinding angles
between 10.4 and 16.2

0

(corrected values, see footnote).

limits are compatible with an unwinding angle of 16.4

These lower

° obtained

for

Hycanthone (see above).
The double helical oligoribonucleic acid poly A•poly U also
binds Miracil D through an intercalation process as concluded from
studies of such complexes (Heller et al., 1974).

N}m

This conclusion was

deduced from the shift and broadening of resonance of the 4-methyl
group of the drug.

Similar but weaker effects were observed with the

single stranded oligoribonucleic acid poly A.

No effect was discerni-

*Unwinding angles were initially calculated relative to an assumed unwinding angle of 12 ° for ethidium bromide (Waring, 1970).
However, since this value was more recently modified to 29 ° (Tsai et
al., 1975), previously reported unwinding angles must be multiplied~y
a factor of 29/12=2.42 to obtain the corrected values.

27

ble with the single stranded oligoribonucleic acid poly

u:

Based on these observations, a structure for the Miracil Dpoly A•poly U complex was suggested, in which carbons 1, 2, 3, and 4
of the thioxanthenone ring are located between the adenine bases, and
the diethylaminoethylamino side chain portion extends from the major
groove of the helix (Figure 7).

This orientation allows a complete

intercalation of the thioxanthenone ring system between the stacked
base pairs, and allows the distal nitrogen atom of the side chain to
reach near the phosphate oxygen atoms of the polymer, making electrostatic interaction between these groups possible.
I.6.3.

The Effect of the Intercalation between Thioxanthenones and

Nucleic Acids on RNA Synthesis
In the enzymatic synthesis of RNA catalyzed by DNA dependent RNA
polymerase (enzyme), the enzyme directs the synthesis of

&~A

from mono-

nucleoside triphosphates according to genetic information encoded in
the template.

The synthesis may be visualized as consisting of a

number of steps.

The commonly accepted steps are (Chamberlin, 1974):

(1) Template (i.e. DNA) binding, in which the enzyme (i.e. RNA polymerase) attaches to the DNA template, locates a specific site at which
chain initiation can occur, and assumes an active conformation. (2)
RNA chain initiation, in which the enzyme catalyzes the coupling of
ATP or GTP with a second ribonucleoside triphosphate (substrate).

In-

organic pyrophosphate is eliminated and a dinucleoside tetraphosphate
is produced.
complex.

This moiety remains tightly bound to the enzyme-template

(3) RNA chain elongation, in which successive nucleoside

monophosphate residues are added from the substrate nucleoside tri-
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Figure 7.

The structure of the Uiracil D-poly A•poly U complex.

Miracil D molecule is intercalated between two adjacent base pairs
(Heller et al., 1974).

The
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phosphates to the 3'-0H terminus of initial dinucleoside tetraphosphate leading to elongation of the nascent RNA chain.

(4) RNA

chain termination and enzyme release, in which the newly formed EllA
chain and enzyme are released from the template.
As a result of the formation of complexes between thioxanthenones and nucleic acids, the template activity of nucleic acids in RNA
synthesis is affected.

The DNA dependent RNA polymerase of E. coli

using calf thymus DNA as template is inhibited by Miracil D (Weinstein
et al., 1967).

This inhibition can be ascribed exclusively to the

interaction of Miracil D with the template DNA since supplementation of
the system with excess DNA reverses the inhibition, whereas supplementation with excess enzyme does not, indicating that the target of
drug action is the template and not the enzyme.

Methyl-Miracil D

produces no apparent inhibition in the same system under similar conditions (Hirschberg et al., 1968c).
Wilson and his coworkers investigated the effectiveness of
Miracil D as inhibitor of

&~A

synthesis using synthetic single and

double stranded ribo- and deoxyribonucleic acids (Wilson et al.,
1972b).

In general, inhibition was most pronounced for polynucleotides

containing deoxyribose and adenine.

Specifically, for double stranded

polydeoxyribonucleotides the following order of relative inhibition was
observed: calf thymus DNA <poly dG•poly dC <
poly d(A-T).

poly dA•poly dT <

The authors concluded that Miracil D has a great affinity

for adenine residues.
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1·7·

Circular Dichroism of Drug-DNA Complexes

1.1.1.

Circular Dichroism Definitions
One manifestation of optical activity is that optically active

compounds or complexes absorb the left and right circularly polarized
lights to different extent.
dichroism.

This manifestation is termed circular

If Beer's law is obeyed for these two kinds of lights,

we have

Ay. =~ • c • 1
~=1\·c•l

where

~, ~

and

~' ~

and
,

are the absorbances and molar extinction

coefficients, respectively, c is the molar concentration of the
substance exhibiting circular dichroism, and 1 is the path length in
em.

The subscripts L and R refer to the left and right circularly

polarized lights, respectively.

The

quantity~-~

From these equations, we obtain

is called differential absorbance

and~-~

is

called differential molar extinction coefficient, expressed in units of
-1

absorbance and liter•Hole

-1

•em

, respectively.

In general, the

differential molar extinction coefficient EL-ER is used to express
the circular dichroism properties of these optically active substances.
As a consequence of the difference in extinction coefficients
for the left and right circularly polarized lights, substances exhibiting circular dichroism polarize the plane polarized light elliptically, that is, if a plane polarized light beam passes through

r

t::.
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i

~.~.;

)

these substances, the emerging light becomes elliptically· polarized.
The major axis of the ellipse is also rotated with respect to the
plane of the incident plane polarized light, resulting in optical
rotation.

The ellipticity 0 (the ratio of the minor to the major axis

of the ellipse) of the emerging elliptically polarized light can be
expressed, if Beer's law is obeyed, as
0=[0]•c•l ,
where 0 is the ellipticity in degrees, c is the molar concentration of
the substance, and [0] is the molar ellipticity in deg•lit•Hole-l•
-1

em

The molar ellipticity [0] and the differential molar extinction
coefficient EL-ER are related according to the equation

Clearly then, in addition to the differential molar extinction coefficient, the molar ellipticity can be used to quantitate the circular
dichroism properties of optically active substances.
1.7.2.

Optical Activity of Drug-DNA Complexes
Many drug and dye molecules that are themselves optically in-

active, become active when bound to DNA.
bromide

(Al~tipis

Typical examples are ethidium

and Martz, 1970), proflavine, acridine orange (Blake

amd Peacocke, 1966), and the aminoacridines (Dalgleish et al., 1969).
All these molecules are derivatives of planar heterocyclic ring
systems, and are known to interact with DNA by intercalation.

For the

characterization of the complexes formed, the concept of the binding
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ratio is a useful parameter.

The binding ratio r is defined as

r

=

~

[P]

where cb is the concentration of drug or dye bound to the nucleic

acid~

and [PJ is the nucleic acid concentration expressed as nucleic acid
phosphorous (Scatchard, 1949).

This quantity is proportional to the

degree of saturation of nucleic acids by the ligand.

If the ligand

exhibits no preference for binding sites of a particular composition,
then the distribution of bound molecules on a linear polymer nucleic
acid can be considered as random.

Therefore, in this case, the binding

ratio r would be inversely proportional to the average physical
distance between bound molecules.
In the circular dichroism spectra of aminoacridine-DNA

and

ethidium bromide-DNA complexes, two kinds of circular dichroism bands
have been described: (1) those, the differential molar extinction coefficients of which are relatively independent of the binding ratio r,
and (2) those, the differential molar extinction coefficients of which
steeply increase with increasing binding ratios.

In the first instance,

the induced circular dichroism appears to be the result of direct
interactions between the symmetric intercalated molecule and the asymmetric binding site of DNA (Jackson and }fuson, 1971).

The value of

EL-ER for an isolated intercalated molecule (which in practice is the
value of E1 -ER at very low r values) is not affected by the presence of
molecules bound to the neighbouring sites.

In the second case, the in-

duced circular dichroism is the result of an interaction between mole-

·.
!
.

~

~-'
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cules intercalated at neighbouring binding sites (Jackson "and

1971).

~~son,

In this case, the differential molar extinction coefficients

are zero or nearly zero at an r of 0 and increase rapidly with increasing binding ratios up to saturation (Dalgleish et al., 1969;
Aktipis and Kindelis, 1973).

Either type or both types of bands ap-

pear in the circular dichroism spectra of these compounds when bound
to DNA.

1.8.

The Scope of This Investigation
As mentioned earlier in this chapter, a number of attempts have

been made to correlate the schistosomicidal, the carcinostatic and the
bacteriostatic activities of thioxanthenones.

However, there does not

seem to be a unique mechanism responsible for all these activities.
The biochemical basis of the schistosomicidal and carcinostatic activities remains elusive.
The bacteriostatic activity of thioxanthenones, however, appears
to be related to the inhibition of cellular RNA synthesis.

Especially

in the case of two well-investigated thioxanthenones, Miracil D and
methyl-Miracil D, a good correlation can be obtained between bacteriastatic activity and the effectiveness of these compounds as inhibitors
of RNA synthesis.

A puzzling aspect among the results of previous

studies has been the reported almost complete ineffectiveness of
methyl-~firacil

D in inhibiting RNA synthesis compared to }-uracil D.

Therefore, this investigation was undertaken to determine whether the
observed differences in the inhibition of RNA synthesis by Miracil D
and methyl-Hiracil D could be related to the physicochemical properties
of the complexes formed ben1een these drugs and DNA, and whether the
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lack of inhibitory effectiveness of methyl-Miracil D could be explained
on the basis of the physicochemical properties of this drug.
In this investigation, the drug-DNA complexes are examined by
means of absorption spectroscopy, circular dichroism, and melting
profiles.
~-

The results of binding studies between DNA and the thio-

xanthenones are used to interpret the relationship between the physicochemical properties of drug-DNA complexes and the inhibitory effectiveness of these drugs.

Circular dichroism measurements are uti-

lized to investigate the structural features of drug-DNA complexes with
special regard to long range changes in DNA conformation leading to exclusion in binding.

Melting profiles of these complexes are studied in

order to establish the relative effectiveness of Miracil D and its
methyl derivative, when bound to DNA, in stabilizing DNA against heat
denaturation, and to obtain insight into the mechanism of inhibiton of
RNA chain elongation by these drugs.
The inhibition of both initiation and elongation of RNA synthesis by these drugs is also investigated.

Miracil D is found to in-

hibit both initiation and elongation of RNA synthesis.

Finally, it is

established that Miracil D and its methyl derivative, when bound to
DNA, are equally effective inhibitors of RNA synthesis.

CHAPTER II
MATERIALS AND METHODS
II.l.

Materials
Calf thymus deoxyribonucleic acid as a white fibrous material

:

,·

was purchased from Worthington Biochemical Corporation (Freehold, New
Jersey 07728) and Sigma Chemical Company (Saint Louis, Missouri 63178).
Bacteriophage T2 (ATCC No. 11303 B ; Host: E. coli B, ATCC No.
2
11303) as a suspension in 0.05 M Tris buffer, pH 7.6, containing 0.1 M
NaCl and 1 mM EDTA, was obtained from Miles Laboratories, Inc. (Elkhart,
Indiana 46514).

The suspension (Control No. 21-6-790) had a titer of

5x1o 12 plaque forming units per ml and an absorbance of 43 per ml at
260 nm.
DNA dependent RNA polymerase (Nucleosidetriphosphate: RNA
nucleotidyltransferase; E.C. No. 2.7.7.6) from E. coli, strain K-12
was purchased from Sigma as a solution in 50 % glycerol and 50 % 0.01 M
Tris buffer, pH 7.9, containing 0.01 M MgC1 , 0.1 M KCl, 0.1
2
threitol, and 0.1

m}1

EDTA.

~1

dithio-

The enzyme solution (Lots No. 33C-2510 and

94C-0284-2) had specific activities of 382 and 565 units/mg, and protein concentrations of 2.10 and 1.77 mg/ml, respectively.

One unit of

enzyme will incorporate 1 nMole of labeled ATP into an acid insoluble
product in 10 minutes at pH 7.9 and 37

0

C, using calf thymus DNA as

template (Burgess, 1969).
Miracil D (1-(4-ethyl-1,4-diazahexyl)-4-methyl-10-thioxanthene9-one) as a yellow crystalline solid was purchased from Calbiochem
36
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(La Jolla, California 92037) under the trade name Lucanthone, as hydrochloride, with a molecular weight of 376.7 daltons (Lot No. 802205).
Methyl-:Hiracil D (1-{4-ethyl-1-methyl-1,4-diazahexyl)-4-methyl10-thioxanthene-9-one) and MDMT {1-{4-methyl-1,4-diazapentyl)-4-methyl10-thioxanthene) as crystalline solids were generous gifts from Dr.
Edward Elslager of Park, Davies & Company (Ann Arbor, Michigan 48106)
and Dr. Frederic A. French of Mount Zion Hospital and Medical Center
(San Francisco, California 94115), respectively.

Methyl-Miracil D was

supplied as dihydrochloride monohydrate with a molecular weight of
445.45 daltons and MD}IT as the free base with a molecular weight of
298.44 daltons.
Sodium salts of the four nucleoside triphosphates ATP, CTP, GTP,
and UTP as white crystalline solids were purchased from Sigma and
P-L Biochemicals, Inc. {Milwaukee, Wisconsin 53205).

The preparations

were at least 97 % pure according to the manufacturer's specifications.
5-[ 3H]-uridine-5'-triphosphate, tetrasodium salt (specific
activity: 19 Ci/mMole) in ethanol-water (1:1) mixture was obtained
from Schwarz/Mann {Orangeburg, New York 10962).

y-[ 32 P]-adenosine-5'-triphosphate, ammonium salt (specific activity: 15.8

Ci/~wle)

as freeze-dried solid was purchased from

Amersham/Searle Corporation (Arlington Heights, Illinois 60005).
All common chemicals used were of analytical grade.
II.2.

Instruments
The following instruments were used in these studies:
Cary Model 15 Recording Spectrophotometer (Varian, Cary Instru-

ments Division, Monrovia, California 91016)
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Jasco Hodel ORD/UV-5 Optical Rotatory Dispersion Recorder
(Japan Spectroscopic Company, Ltd., Tokyo, Japan) equipped with CD
attachement and modified (SS-10 modification) to a maximum sensitivity of 0.002 degrees of ellipticity per em
Beckman :Hodel LS-250 Liquid Scintillation System (Beckman
Instruments, Inc., Fullerton, California 92634)
Beckman

TM

Analyzer (Beckman Instruments, Inc., Fullerton,

California 92634)
Beckman Temperature Bridge (Beckman Instruments, Inc., Fullerton,
California 92634)
¥~seley

Model 7035B X-Y Recorder (Hewlett Packard Corporation,

Palo Alto, California 94304)
International Model PR-2 Portable Refrigerated Centrifuge
(International Equipment Company, Needham Heights, Massachusetts 02194)
Beckman/Spinco Model L Ultracentrifuge (Beckman Instruments,Inc.
Spinco Division, Palo Alto, California 94304}
Corning Model 12-B Research pH Meter (Corning Scientific
Instruments, Medfield, Massachusetts 02052)
Lauda/Brinkman 110del K-2/R Refrigerated Circulator (Brinkman
Instruments, Inc., Westbury, New York 11590)
11.3.

Purification of Miracil D
Miracil D (0.4 g) was dissolved in 50 ml distilled water at

50 °C.

The solution was titrated with 50 % sodium hydroxide solution

until no further precipitation was observed (about pH 11).

The pre-

cipitate was collected on a sintered glass filter and redissolved in
absolute ethanol at 50 °C.

Concentrated hydrochloric acid (10 rnl) was

1
f
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added and the Miracil D 'tvas crystallized at 4

r.-·

°c.

The crystals were

dried over Drierite dessicant (anhydrous Caso ) and stored in a dark

4

bottle at 4 °C.
Thin layer chromatography was performed in the following solvent
systems (Zilversmit, 1970): butanol/acetic acid (9:1), chloroform/
methanol (9:1), ethyl acetate/n-heptane (6:4), and ethanol/ammonium
hydroxide (9:1).
preparation.

No contaminants could be detected in the purified

The melting point was 195

0

C, in agreement with Mauss

(Mauss, 1948).
II.4.

Preparation of Deoxyribonucleic Acid from Bacteriophage T2
Deoxyribonucieic acid from bacteriophage T2 was prepared by the

method of Bautz and Dunn (Bautz and Dunn, 1971).
Commercial bacteriophage suspension (5 ml) was dialyzed versus
2 liters of 0.1 M sodium phosphate buffer, pH 7.2 for 5 hours.

The

dialyzate was transferred into a 10 m1 test tube and 0.55 ml of
freshly prepared 10 % sodium dodecyl sulfate solution was added.

The

mixture was then placed into a water bath and the temperature was
raised to 65 °C.

The mixture after three minutes at this temperature

became quite viscous.

After chilling on ice, 1 ml of 2 M KCl solution

was added in small portions with gentle swirling.
of potassium dodecyl sulfate and protein appeared.

A white precipitate
The mixture was

then poured into a polyallomer centrifuge tube and centrifuged at
27,000 g and 4

0

C for fifteen minutes in the Beckman/Spinco ModelL

ultracentrifuge using the swinging bucket rotor Sl-1 36 (at 16,000 rpm).
The supernatant containing the T2 DNA was decanted into a conical
stoppered glass centrifuge tube and the pellet was discarded.

6.5 m1

•·' .
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of freshly distilled phenol (collected between 176 and 178 °C) containing 0.08 % of 8-hydroxy-quinoline and saturated with 0.1 M sodium
phosphate buffer, pH 7.2 was added to the supernatant and the mixture
was rocked for 30 minutes at room temperature with a frequency of about
40 cycles/minute.

After centrifugation in the International Model PR-2

Portable Refrigerated Centrifuge using head No. 296 at 2,000 rpm and
4 °C, the top aquaeous phase was transferred into a polyallomer centrifuge tube and was further centrifuged at 27,000 g for 30 minutes as
described above.

The supernatant was decanted and dialyzed against 1

liter of 0.01 M Tris-HCl buffer, pH 7.3, containing 0.01 M KCl and
0.5 mM EDTA.

The dialyzis was performed at 4

daily changes of the buffer.

0

C for four days with

The resulting T2 DNA solution was stored

at 4 °C.

'

This DNA preparation had a melting temperature of 86

0

C and

46 % hyperchromicity at 260 nm in 0.08 M Tris-HCl buffer, pH 7.0, containing 0.4 M KCl and 0.02 M Mgcl 2 •

The A260

!Az80

ratio was 1.75,

indicating low protein contamination (Thomas and Abelson, 1966).
T2 DNA concentrations were determined spectrophotometrically
using an extinction coefficient of 6500 at 260 nm (Mahler et al., 1964)
and a mean residue weight of 357 daltons (Rubinstein et al., 1961).
II.5.

Preparation of Stock and Working Solutions
Calf thymus DNA was dissolved (3-4 mg/ml) in 0.01 M sodium

chloride solution with slow stirring at 4

0

C for 48 hours.

The so-

lution was then dialyzed twice, each time against 40 volumes of 0.01 M
sodium chloride solution for 24 hours at 4 °C.
solution was stored at 4

0

C.

The resulting DEA stock
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Before each experiment, a working DNA solution was·prepared by
diluting the DNA stock solution with the appropriate buffer.

The

concentration of DNA was determined spectrophotometrically using a
r

molar extinction coefficient of 6600 liter/cm/N:ole of DNA phosphorous
(Mahler et al., 1964) or a specific extinction coefficient of 20 liter/
cm/g of DNA (Nakamoto et al., 1964).
Working solutions of Miracil D, methyl-Miracil D, and MDMT were
prepared by dissolving these compounds in buffer.

For this purpose,

the purified Miracil D preparation (see section II.3) was used, while
both methyl-Miracil D and MDHT were used as supplied (see section II.1).
Drug concentrations were determined spectrophotometrically using the
follow i ng est i mate d mo 1 ar

'
'
ext~nct~on

.
' 1'~ter• Mo 1e- 1 •em- 1 :
coeff'~c~ents
~n

Miracil D

8040 at 330 nm

Methyl-Miracil D

3600 at 425 nm

MDI-IT

3900 at 302 nm

These molar extinction coefficients in buffer were calculated on the
basis of the weighed amounts (about 10 mg) and the molecular weights of
the compounds specified by the suppliers (see section II.1).
Unlabeled nucleoside triphosphate solutions were prepared simply
by dissolving the salts in deionized water (total volume not more than
1 ml).

The solutions (pH 4) were titrated with 50% sodium hydroxide

solution to pH 7.0 using 1

~1

chromatographic applicators.

Radioactively labeled nucleoside triphosphate solutions were
prepared by dissolving the solid commercial preparations in unlabeled
nucleoside triphosphate solutions.

l~enever

these preparations were in
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liquid form, they were placed in an ice bath and dried under a stream
of nitrogen.
11.6.

Preparation of Drug-DNA Complexes
Drug-DNA complexes were prepared from working solutions (see

section 11.5) of the drugs and DNA.

Since the drug solutions have a

tendency to be retained on the inner surfaces of glass pipettes used
for transfer, a specific procedure was used for the preparation of the
complexes to insure greater accuracy.

Since in the binding studies and

circular dichroism measurements the drug concentration was maintained

-5 M and the DNA concentration was varied as appropri-

constant at 2xl0

ate, typically, 5 g of drug solution was weighed into a 25 ml volumetric flask followed by the addition of the required volume of DNA working solution, and filled up with buffer to volume.
II.7.

Dimerization Studies
Solutions for these studies were prepared from working solution

of Miracil D by weighing a given amount and diluting it with buffer to
the required final volume.

The concentration ct of the drug in these

solutions and the path length 1 of the spectrophotometric cells were
selected so that the product ct•l was identical for each sample.

This

method permits isosbestic points to be located by visual inspection of
the resulting spectra.
Absorption spectra of drug solutions in the near ultraviolet
wavelength region were recorded at room temperature.

Because of the

tendency of the drug to be absorbed to the surfaces of the glassware,
spectra were recorded immediately following the preparation of the
solutions.

Scanning rates were about 1.6 ~/sec, the slowest possible

·.
in order to insure the most accurate recorder pen response.
'
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Both rec-

tangular and cylindrical fused silica cells of different pathlengths
were used.
For the determination of the dimerization constant, the method
of Lamm and Neville (Lamm and Neville, 1965) was utilized.
is based on the following principle.

This method

In a solution containing the

monomeric and dimeric forms of a compound, the laws of mass conservation
and mass action can be stated as

and

where c's are the molar concentrations, the subscripts m and d refer to
monomer and dimer, respectively, and Kd is the dimerization constant.
From the law of mass action, the dimer concentration cd can be expressed
as

2

cd=Kd·~

•

Substitution for cd in the law of mass conservation
2
yields the relationship 2•Kd·cm+cm-ct=O , which is quadratic in the

monomer drug concentration em •

Using the general solution formula of

quadratic equations gives

Defining a as the fraction of drug present as monomer by a=cm/ct,
a can be expressed as a function of ct and Kd:
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V1+8·K

d

•C

-1

a--------------t

(1)

4-Kd.ct

If the monomer and the dimer are the only two absorbing species,
the absorbance A of the solution can be expressed as the sum of contributions from the monomer and dimer:
A=E

•C

m

·l+E

m

d

•C

d

·1 ,

where Em and Ed are the molar extinction coefficients of the monomer
and dimer, respectively.

By defining the apparent molar extinction

coefficient E
of a solution as E
=A/(c ·1), it follows that
app
app
t

Eapp =(Em-Ed/2)·a+Ed/2 •

(2)

This indicates that the apparent molar extinction coefficient is a
linear function of a, and the slope and the intercept of theE
. app
versus a line are determined by the molar extinction coefficients of
the monomer and dimer.
The linear property of equation (2) was used in the determination of the dimerization constant.

First, arbitrary values were

assigned to Kd and the fraction a of drug present as monomer was calculated according to equation (1) for each sample and each Kd.

Using

these a values and the corresponding apparent extinction coefficients,
which were obtained experimentally, the best straight line fit to
equation (2) was calculated by the method of non-weighted leastsquares.

The procedure was repeated with different values of Kd until

a minimum was reached in the root-mean-square deviation between the
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experimentally obtained apparent molar extinction coefficients and the
computed best straight line values.

The Kd is the dimerization

constant of the drug most compatible with the experimental results.
For the Kd value that gives the minimal root-mean-square devi~

ation, the slope and the intercept of the best fitting straight line
can be used to determine the monomer and dimer molar extinction coefficients.
11.8.

Binding Studies
The binding of thioxanthenones to nucleic acids was investigated

by the spectrophotometric method of Peacocke and Skerrett (Peacocke and
Skerrett, 1956).

The method utilizes, as a binding parameter, the

change in the absorption spectrum of the ligand as it binds to the
nucleic acids.
The absorption spectra of drug-nucleic acid complexes were recorded in the visible and near ultraviolet wavelength regions.

A

buffered solution of DNA with a concentration equal to that present in
each drug-DNA complex was employed as reference.

For these measure-

ments, fused silica cells of 5 and 10 em pathlengths were used.

The

procedures described for the dimerization studies (see section !!.7)
were used for recording the spectra.
!!.8.1.

The Analysis of the Spectra of Drug-Nucleic Acid Complexes
The method of Peacocke and Skerrett was also used for the a-

nalysis of the spectra.

A brief description of this method is pre-

sented below.
For a mixture of free and bound ligands in the presence of
nucleic acids, Beer's law and the law of mass conservation can be
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stated as

and

~here

A, E's, c's and 1 are the absorbance, the molar extinction coef-

ficients, the molar concentrations, and the pathlength, respectively.
The subscripts t, f, and b refer to the total, free, and bound ligands,
respectively.

It is assumed that both the free and bound ligands them-

selves obey Beer's law and that the DNA does not absorb light at the
wavelength selected for the study.

Any deviation from the principle of

additivity is considered as evidence for the presence of more than one
kind of species of free or boun4 ligands.
The absorbance of the mixture of free and bound ligands can be
expressed from these equations as

If a wavelength can be found for which Ef=Eb, then A=Ef•ct•l, which
means that the absorbance of the mixture is independent of its composition.

This wavelength is called the isosbestic wavelength.
In practice, a series of solutions are prepared with identical

ligand concentrations and varying nucleic acid concentrations.

If an

isosbestic wavelength is present then the spectra of all complexes
cross through a single point (isosbestic point) at the isosbestic wavelength.

The existence of an isosbestic point is a good indication of

the presence of only two kinds of absorbing species.

Obviously, the
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lack of an isosbestic point does not preclude the possibility that only
two kinds of absorbing species are present.
For the absorbance Af of the solution which does not contain
bound ligand, we have

Af =E f

•c

t

•1

,

and for the absorbance Ab of the solution which does not contain free
ligand, we have

A_ =E
l>

b

•c

t

•1

By combining these relationships, the concentration of bound ligand
can be calculated according to the equation
A -A

f
c =-------•c

b

A -A
f
b

t

To improve the accuracy of the determination of cb, a wavelength is selected for the measurements which maximizes the value of
II.8.2.

Af-~·

The Determination of the Absorption of Bound Drug
In general, the value of Ab is not available experimentally.

For its determination, the method of Crothers (Crothers, 1974) was
used with some modifications.

According to this method, at extremely

high nucleic acid concentrations [P], the double reciprocal relationship
1

1

1

1

------=-------+-------------------·--Af -A
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where Kapp and Ba pp are the apparent binding constant and· the apparent
number of binding sites, respectively, can be used to obtain the value
of the absorption Ab of bound drug.

This is possible because the plot

of the reciprocal differential absorbance 1/(Af-A) versus the reciprocal nucleic acid concentration 1/[P] should yield a straight line with
an intercept of 1/(Af-Ab).

Since at low nucleic acid concentrations

deviations from linearity are known to occur (Hayman, 1962), a polynomial rather than linear extrapolation was used to obtain the value
of the intercept.

The calculations were performed using the computer

program POLFIT available from the Public Library of the Computer Center
at Loyola University of Chicago.
II.8.3.

Scatchard Plots and Their Interpretation
For the presentation of the results of binding studies, the

method of Scatchard was chosen (Scatchard, 1949).

Plots of r/cf

versus r were prepared, where the binding ratio r is defined by

cb

r=---- •

(3)

(P]

The values of r/cf and r were calculated directly from absorbance
measurements using the equations
1

r

----=------·--and
Af-A

ct

r=-------·---- .
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The binding of thioxanthenones to nucleic acids was interpreted
on the basis of the exclusion model for binding (McGhee and von Rippel,

f.

•

1974).

According to this model, i f the binding of ligands to nearest

neighbour sites of nucleic acids is not allowed, then the binding isotherm may be described by the equation
2
r
(l-4•r)
----=K·---------cf
2• (1-2·r)

(4)

~

R

where K is the .intrinsic association constant between the ligand and
the nucleic acid.
The intercepts of the isotherm with the r and r/cf axes must

~'

be located at r=0.25 and r/cf=K/2, respectively, and the isotherm must
always fall below the line determined by these intercepts.

The

curvature of the isotherm is most pronounced in the region of 0.125 <
r < 0.25.

The fitting of the exclusion model to the experimental data was

\.

performed using the computer program described in Appendix B.

In this

procedure, arbitrary values were given to K and the theoretical binding
isotherms were calculated.

The K which produced an isotherm which fit

the experimental points within experimental error was assumed to be the
true intrinsic association constant.

A maximum error of 0.003 in ab-

sorbance and an error of 1.5 % in nucleic acid concentration was assumed throughout all calculations.
II.9.

Circular Dichroism Measurements
Circular dichroism measurements were carried out on the Jasco

Model ORD/UV-5 Optical Rotatory Dispersion Recorder.

The instrument
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was calibrated with an 0.1 % aquaeous solution of d-10-camphorsulfonic
acid (supplied by Durrum Instruments Corporation, Palo Alto, California
94303).

This standard solution placed in a 1 em spectrophotometric

cell gives an ellipticity of +0.313 degrees at 290 nm, corresponding to
J.

a pen deflection of 15.65 em on the 0.02 degrees/em scale of the
spectropolarimeter.
The circular dichroism spectra of drug-DNA complexes were recorded in 5 and 10 em cylindrical fused silica cells at room temperature.

The absorbance of the samples was always maintained below 2.0

in order to avoid artifacts in optical activity.
The results of circular dichroism measurements are reported

f

~
~

either as differential molar extinction coefficients EL-ER or differ-

~

f;
~

entia! absorbance AL-AR.

They were calculated using equations

'

f
0

-A =---• L R 33
t\.

and
0

EL-ER=-------- ,
33•c•l

(5)

where the ellipticity 0 (in degrees) was read directly from the chart
paper, 1 is the pathlength in em, and c is the molar concentration of
species responsible for the circular dichroism.

Therefore, the values

of AL-AR and EL-ER were obtained in units of absorbance and liter•
Mole

-1

•em

-1

, respectively.

~.·
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1].10.

Measurements at Elevated Temperatures

~

!

L

1].10.1.

Definitions, Terminology, and Formulas Used in Hyper-

£Promicity Measurements
Hyperchromicity his defined (Mahler et al., 1964) by theequation

At

h=----- -1 '
At
where At and At

0

are the absorbances of a hyperchromic substance at a
0

given wavelength, temperature t, and reference temperature t o •

There-

fore, hyperchromicity measurements are carried out by the measurement
of absorbance as a function of temperature.

The instrumentation used

for these studies is described in the next section.
A typical set of hyperchromicity versus temperature plots (also
referred to as melting curves or melting profiles) of nucleic acids and
drug-nucleic acid complexes are shown in Figure 8.

It can be seen that

the hyperchromicity increases, reaching a maximum plateau, with increasing temperature.
denoted by

h,

If the maximum hyperchromicity value reached is

the melting temperature Tm is defined as the temperature

at which 50 % of the maximum hyperchromicity is attained (Mahler et
al., 1964), that is
h(Tm)=0.5•h .
This classical definition is readily applicable for melting curves
representing a single cooperative transition restricted to a relatively
narrow temperature range (Figure 8, curve a).

For cases where the
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Figure 8.

Typical dependence of hyperchromicity h on the temperature

of nucleic acids and drug-nucleic acid complexes (see text for details).

i·ll
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transition is more complex and it takes place in a relatively wide
temperature range, a modified melting temperature
and Jordan, 1965).

T~

is defined (Gersch

According to this new definition,

T~

is the temper-

ature at which 50 % of the maximum hyperchromicity is attained from
the onset of the rapid increase to the maximum of hyperchromicity.

The

intercept of the extrapolated linear segments of the melting curves
determines the onset of the rapid increase (Figure 8, curve b).

In

the present investigation both the classical and modified definitions
for melting temperatures are used.

Reference to the appropriate

melting curve indicates which definition is applicable in each instance.
In the presentation of the present experimental results, the normalized
hyperchromicity hn will be used, which is defined by the equation
h

hn=-=- •
h

Since melting temperatures are invariant to this linear transformation,
they can be determined directly from the normalized hyperchromicity
versus temperature plots.
In the present studies, the reference temperature is 25
the maximum hyperchromicity is obtained at 98

-

0

0

C, and

C, i.e.

A9s

h=h(98)=----- -1 ,
A25
so the normalized hyperchromicity hn at temperature t was calculated
using the equation
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(6a)

Measurements of absorbance as a function of temperature were
also carried out at wavelengths where the nucleic acids do not absorb
light (i.e. 440 nm).

The changes of absorbance at these wavelengths

are the result of drug dissociation from the drug-nucleic acid
complexes.

For the quantitative treatment of drug release from the

complexes, the normalized absorbance change

~A

n

is used, which is

calculated using the equation

~A

n

=~~=~£2_

(6b)

A98-A25

For the normalized absorbance change

~A

n

versus temperature profiles,

the concept of dissociation transition temperature of drug-DNA
complexes, corresponding to the melting temperature T

m

profiles, can be introduced.

of melting

The dissociation transition temperature

of drug-DNA complexes is the temperature at which 50 % of the maximum
normalized absorbance change is attained.

At this temperature, 50 %

of the drug bound at the reference temperature (i.e. at 25 °C) is released from the complex.
!!.10.2.

Instrumentation

The dependence of absorbance and circular dichroism on temperature was studied by the simultaneous recording of absorbance or circular dichroism and temperature of drug-DNA complexes.
Solutions were placed in a special heated cell holder assembly
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modified part of the Beckman TM Analyzer) , which can be fitted with-

in the sample compartments of the Cary Model 15 Recording Spectrophotometer or the Jasco Model ORD/UV-5 Spectropolarimeter.

The tempera-

ture of the cell holder assembly can be linearly increased at a
programmed rate by means of the Beckman TM Analyzer.
3 °c/minute.

The. rate used was

The sample temperature was measured, using the Beckman

Temperature Bridge, which monitors the temperature of distilled water
in a cell adjacent to the sample cell within the cell holder assembly.
The Analyzer produces an electrical signal (between 0 and 10 mV) ,
proportional to the temperature of the sample.

Potentiometers installed

on the pen drive shafts of the spectrophotometer and spectropolarimeter
produce resistances (between 0 and 10 kQ) , proportional to the absorbance or the circular dichroism of the sample under examination.
The potentiometers are connected through a custom-made calibration box
to the Y-axis input of the Moseley Model 7035B X-Y Recorder (Martz and
Aktipis, 1971).

The calibration box serves two purposes.

One is to

transform the resistances of the potentiometers to electrical signals
and the other to provide for expansion and baseline adjustments of the
electrical signal.

The signal from the Beckman Temperature Bridge is

directly _applied to the X-axis input of the recorder.

With this instru-

ment assembly it is possible to obtain directly the absorbance or circular dichroism as the function of temperature.
11.10.3.

Determination of the Dependence of Association Constants

on Temperature
The dependence of the intrinsic association constant K for the
binding between drug and nucleic acid on the temperature can be de-

'·
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termined by combining the results of binding studies at room temperature with the results of absorbance measurements at 440 nm as the
function of temperature.

Since the increase of absorbance at 440 nm is

the result of drug release from the drug-DNA complexes, therefore,
hA (t) denotes the fraction of the drug which is bound at 25
n

°c,

but

which is released at temperature t, i.e.
~(25)-cb(t)

hA (t)=-------------- ,
~(25)
n
from which
(7)

Dividing by the nucleic acid concentration [P] and using the definition
of the binding ratio r, we obtain
r(t)=r(25)•[1-hAn(t)] .

(8)

In this formulation it is assumed that both the free and bound drug
extinction coefficients are independent of temperature or that if these
coefficients depend on it, their dependence is small and such that equation (8) is still obeyed.

From equations (3) and (4), the intrinsic

association constant K can be expressed as
2•r•(l-2•r)

K=--------2-----------.
(1-4•r) •(c -r·[P])

(9)

t

From the known values of the normalized absorbance changes at
temperature t and of the intrinsic association constant K at room
temperature, the intrinsic association constant K at temperature t can
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be calculated using equations (8) and (9).

The results of these calcu-

lations are reported as log 10K versus 1/T (van't Hoff plots), where T
is t h e a b so 1 u t e t empera t ure.
(2.303•R), where flH

0

0
/
•
• equa 1 to -AH
Th e resu lt 1ng
s 1 ope 1s
u

and Rare the standard enthalpy change and the gas

constant, respectively.

The standard enthalpy change 6H0 can be calcu-

lated from the slope of the van't Hoff plots.
gy change 6G

0

The standard free ener-

and the standard entropy change 6S 0 can be calculated

using the equations
6G0 =-R•T•lnK
and

(Klotz and Rosenberg, 1972).
11.10.4.

Measurements of the Circular Dichroism of Drug-DNA Complexes

at Elevated Temperatures
Investigations of the dependence of circular dichroism on the
temperature were performed with instrumentation similar to that used in
hyperchromicity measurements except that the spectrophotometer was replaced by the spectropolarimeter (see section 11.10.2).

The dependence

of the differential molar extinction coefficient on the temperature was
calculated in the following way.

From equations (3) and (7) (see

sections 11.8.3 and 11.10.3, respectively), the bound drug concentration cb(t) at temperature t can be expressed as

where r(25) is the binding ratio at 25 °C, [p] is the nucleic acid
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concentration, and
ature t.

~A

n

(t) is the normalized absorbance change at temper-

Using the equation for

~A

n

(t) (equation (6b), section

11.10.1), we have

cb(t)=r(25)·[P]· {1-

At-A25

---------} .
A98-A25

Substitution of this expression into equation (5) (see section 11.9)
gives
0
t
(Et-ER)t=--------------------------------------- •
33•l•r(25)•[P]•{1-(A -A )/(A -A )l
t 25
98 25

The differential molar extinction coefficient

(EL-~)t

at temperature t

was calculated according to this equation, where the ellipticity et at
temperature t was directly read from the recorder chart paper (see
section 11.10.2), the path length 1 was 1 em in each instance, and the
absorbances A , A , and At at 440 nm (see section 11.10.3 as well)
25
98
were directly read from the recorder chart paper (see section 11.10.2).
11.11.

RNA Polymerase Assays
DNA dependent RNA polymerase activity was determined by the

method of Richardson (Richardson, 1973) with minor modifications.

In

this method the enzymatic activity is determined by measuring the incorporation of radioactively labeled nucleoside triphosphates into
ribonucleic acid insoluble in 5 % trichloracetic acid.
Assay mixtures were prepared with Hamilton syringes in 10x75 mm
disposable glass test tubes.
preheated at 180

0

The test tubes and all glassware were
.

C for at least 48 hours before use in order to in-
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activate any possible nuclease contamination (Sreevalsan; 1973).

Dis-

posable plastic gloves were worn in the course of this work to prevent
any contamination by skin nucleases.
The three major components of an assay mixture, i.e.: DNA dependent RNA polymerase (the enzyme), DNA (the template) with or without inhibitor, and the four nucleoside triphosphates NTP (the
substrates) were dissolved in 0.1 ml of buffered solution with the
following composition:
0.04 M Tris-HCl, pH 7.0 at 25 °C
0.2 M KCl

0.01 H MgC1 2
0.1 mM EDTA
0.1 mM dithiothreitol

0.4 mg/ml bovine serum albumin
A solution with the same composition but in which the concentrations
of the components are 2.5 times higher will be referred to as buffer A.
In these experiments, the template solution with or without inhibitor was prepared in a total volume of 45 lll in an ice bath from
deionized water, DNA stock solution (see section II.S) and an unbuffered
solution of the inhibitor.

The latter solution was titrated to pH 5.0

before use, in order to prevent the precipitation of DNA by the inhibitors.

After the addition of 37 lll ice-cold buffer A to the template

solution, the enzyme was added in 3 lll of an ice-cold solution consisting of commercial enzyme solution, deionized water, and 3 lll of
buffer A.

The mixture was transferred to a 37

0

C water bath and was
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incubated for 6 minutes.

The reaction was then initiated"by the rapid

addition (using Hamilton syringe) of 10 lll of a solution consisting of
3
ATP, CTP, GTP, and 8-[ H]-UTP (specific activity: 4.99 counts/minute/
pMole of UTP) at a concentration of

5~~

each (i.e. ten times the final

concentration) in deionized water, pH 7.0.

The reaction was allowed to

proceed for 8 minutes at 37 °C, and it was terminated by the addition
of 1 ml of freshly prepared ice-cold 5 % trichloracetic acid solution
containing 0.05 M sodium pyrophosphate.
After thorough vortexing and standing in ice for at least 20
minutes, but not longer than 90 minutes, the insoluble material was
collected by filtration through Whatman GF/C filter disks (2.4 em in
diameter).

The precipitate on the disks was rinsed with 20 ml of

ice~

cold 5 % trichloracetic acid solution containing 0.05 M sodium pyrophosphate.

The precipitate was further washed with 30 ml of ice-cold

95 % ethanol and then dried under vacuum overnight.
The radioactivity retained on the disks was counted after adclition of 10 ml of 0.4 % 2,5-diphenyloxazol solution in toluene.
The radioactivity absorbed and retained by the filter disks
themselves and the radioactivity trapped within the precipitated comportents of the assay mixtures was determined from the residual radioactivity of blanks which did not contain any enzyme.
The specific activities of nucleoside triphosphate solutions
were determined from measurements carried out using 10 lll aliquots of
these solutions.

These aliquots were placed on filter disks, dried

under vacuum overnight, and then counted as described above.
Experiments, in which the template concentration or the reaction

f~'

t:
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time were varie d , were per f ormed in the a b sence of inhibitors.

The

same experimental procedure described above was used with the exception
that in the case of experiments in which the reaction time was varied,
0.1 ml aliquots were removed at different times from a master

~ssay

mixture (1.2 ml) and dispensed into 1 ml of ice-cold 5 % trichloracetic
acid solution containing 0.05 M sodium pyrophosphate.

The mixture was

filtered and dried as described above.
Experiments designed to measure the inhibition of ribonucleic
acid chain initiation were conducted as described above except that a
nucleoside triphosphate solution consisting of y-[

32

P]-ATP, CTP, GTP,

3
and 8-[ H]-UTP (specific activities: 2200 cpm/pMole of ATP and 27 cpm/
pMole of UTP, respectively) at a concentration of 2.5 mM for each
nucleoside triphosphate (ten times the final concentration) in deionized
water, pH 7.0 was used.

In these experiments 7 minutes preincubation

and 7 minutes incubation were employed.
Special procedures for terminating the reaction and for washing
were used for the experiments involving

32

P incorporation, so as to

reduce the high background due to unincorporated radioactivity, which
were noted.

Reactions were terminated by the addition of 0.5 ml ice-

cold 0.1 M sodium pyrophosphate solution containing 20 mM ATP and 2 mM
UTP and 0.5 ml of ice-cold 10 % trichloracetic acid solution containing
1 M KCl.

The insoluble material collected on the filter disks was

soaked in 50 ml of ice-cold 5 % trichloracetic acid solution containing
1 H KCl and 0.01 M sodium pyrophosphate for 1 hour, and further soaked
in 40 ml of ice-cold 95 % ethanol for 20 minutes.

The filter disks

were dried as before and placed in 10 ml of 0.4 % 2,5-diphenyloxazole

r·

1.:

t
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olution in toluene for counting the radioactivity.
Simultaneous counting of

3

H and

32

P activities were performed

in the Beckman Model LS-250 Liquid Scintillation System using the
32
3
below 14c and
P above H Isosets at a gain setting of 310.

3
H

Under

these counting conditions less than 2 % activity spill-over between
3H and

32

P could be detected.

,.
CHAPTER III
EXPERit1ENTAL RESULTS
III.l.

Dimerization Studies
The ultraviolet spectra of Miracil D in 0.01 M sodium acetate

buffer, pH 5.0 over a 50-fold concentration range are shown in Figure 9.
In dilute solutions, the absorption maximum is at 330 nm with a shoulder
around 350 nm.

As the concentration is increased, the shoulder becomes

more pronounced and the absorption peak decreases in intensity and
shifts to longer wavelengths.
does not obey Beer's law.

As it can be seen in Figure 9, Miracil D

The existence of isosbestic points at 303.5

and 352 nm indicates that two spectral species are present over the
concentration range of 10-3 to 2xl0 -5 M.
For the determination of the dimerization constant Kd, the method
of Lamm and Neville (Lamm and Neville, 1965) was used (see section
II.7).

In the calculations, absorbances of Miracil D solutions in the

range between 315 and 350 nm at 2.5 nm intervals (a total of 15 wavelengths) were used.

The root-mean-square (RMS) deviation in absorbance

units as the function of the dimerization constant Kd is shown in
Figure 10.

The minimum value of the RMS deviation is at Kd=406

-1

~

and

this value is assumed to be the dimerization constant of Miracil D in
0.01 M sodium acetate buffer, pH 5.0.

At its minimum, the

~MS

deviation

is only 0.002 which is within the limits of the error specifications of
the spectrophotometer used.
According to equation (2) (see section II.7), the apparent ex64
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Figure 9.

The absorption spectrum of Miracil D in 0.01 M sodium ace-

tate buffer, pH 5.0 at room temperature.
(a) 2x10

Miracil D concentrations:

-5 M in 5 em cell, (b) 5x10- 4 M in 0.2 em cell, and (c)

in 0.1 em cell.
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Figure 10.

The dependenc_e of the root-mean-square (RMS) deviation (in

units of absorbance) on the dimerization constant Kd of Miracil D at
room temperature.

1
A minimum is observed at K =406 M- •
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tinction coefficient Eapp is a linear function of the fraction
drug present as monomer.

a,

of

To illustrate the precision of the fit with

-1

Kd =406 -M , the apparent extinction coefficient Eapp of Miracil D solutions as a function of
Figure 11.

a,

at 315, 320, 325, and 330 nm is presented in

The straight lines calculated on the basis of equation (2)

1
and a Kd value of 406 M- , are the best fitting lines to the experimentally obtained apparent extinction coefficients.
The dimerization of Miracil D was also investigated in 0.2 M
sodium acetate.buffer, pH 5.0 at room temperature.
-1

dimerization constant Kd of 410 M

A value for the

was obtained, indicating that the

dimerization is practically independent of ionic strength in the ionic
strength range studied.
Since the pKa 's for Miracil D are -0.20 and 7.4, in aquaeous
solutions at pH 5.0 the drug is present as a positively charged ion
with a single charge localized on the distal nitrogen atom.

Therefore,

the present dimerization studies describe an equilibrium between the
singly charged monomeric and doubly charged dimeric forms of the drug.
III.2.

Binding Studies

!11.2.1.

The Binding of Miracil D to Calf Thymus DNA at 0.01 and

0.2 M Salt Concentrations
The binding of Miracil D to calf thymus DNA was investigated in
0.01 M sodium acetate buffer, pH 5.0 at room temperature.

In these

measurements, the concentration of Miracil D was maintained constant
at 2x10 -5 M, while the DNA concentration was varied.

The absorption

spectra of Miracil D-DNA complexes are shown in Figure 12.
Free Miracil D exhibits an absorption maximum at 330 nm with
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Figure 11.

The dependence of the apparent extinction coefficient

E
on the fraction a of Miracil D present as monomer at various
app
wavelengths as indicated in the figure.
-1
lated with Kd=406 M •

The straight lines are calcu-
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Figure 12.

The absorption spectra of

~liracil

D-DNA complexes in 0.01 M

sodium acetate buffer, pH 5.0 at room temperature obtained in 5 em
cells.

Miracil D concentration: 2x10 -5 M, DNA concentrations: (a) 0,

(b) 8.4x10

-6

M, (c) 5x10

-5

M, and (d) 3.4x10

-4

~-
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8 slight shoulder centered around 352 nm.

Upon addition of DNA, the

intensity of the maximum decreases, the maximum shifts to longer wave·

~f.

lengths, and the shoulder becomes a little more pronounced.
highest DNA concentration (3.4xl0

~

At the

M), the maximum shifts to 337 nm •

..

QUalitatively similar spectral changes were observed for the interaction of other intercalating drugs, such as ethidium bromide (Waring,
1965), proflavine (Dourlent and Helene, 1971), and acriflavine (Tubbs
et al., 1964) with nucleic acids.

The existence of three isosbestic

points at 304, 352, and 364 nm indicates that only two spectral species
are present.

The largest changes of absorbance were obtained at 325 nm

and, therefore, absorbances at this wavelength were used in calculating
the binding parameters.
Since the value of the absorbance of the bound drug,

~·

is not

generally obtainable experimentally, it was determined from the plot of
the reciprocal differential absorbance 1/(Af-A) versus the reciprocal
nucleic acid concentration 1/[p] (see section II.8.2), which is presented in Figure 13.

As it can be seen, the plot is not linear in the

experimentally available nucleic acid concentration region, and,
therefore, a standard polynomial curve fitting procedure was used to
obtain the intercept of the best fitting polynomial (solid line) with
the ordinate.
The Scatchard plot of the binding of Miracil D to calf thymus
DNA in 0.01 M sodium acetate buffer, pH 5.0 at room temperature is
shown in Figure 14.

The experimental points are shown together with

the calculated theoretical isotherm obtained using an intrinsic association constant of 1.2x10

6

-1
M •

The isotherm describes the binding of
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Figure 13.

A plot of reciprocal differential absorbance 1/(Af-A)

reciprocal DNA concentration 1/[P] for determining the absorbance Ab of
bound drug (see text for details).
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Figure 14.

The Scatchard plot of the binding of Miracil D to calf

'~£1

thymus DNA in 0.01 M sodium acetate buffer, pH 5.0 at room temperature.

j

The experimentally obtained points are shown together with the calcu-

j

lated isotherm (solid line) for an intrinsic association constant of
1.2x10

6 M-1 •
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Miracil D to calf thymus DNA on the basis of the exclusion model.

In

this model, it is assumed that the binding of one Miracil D molecule to
DNA prevents the binding of other Miracil D molecules to the nearest
neighbour binding sites.

The validity of this assumption will be

discussed in section IV.2.

The calculations were performed as out-

lined in section II.7.
The binding of Miracil D to calf thymus DNA was also investigated in 0.2 M sodium acetate buffer, pH 5.0 under identical experimental conditions.

For this case, the Scatchard plot and the calcu-

lated theoretical isotherm determined by an intrinsic association
constant of 4.5x10

4 -1
M

are shown in Figure 15.

At Miracil D concentrations of 2x10

-5

M more than 98 % of the

drug is present as a monomer with a single positive charge (Kd's of
-1

406 M

-1

in 0.01 M sodium acetate buffer, pH 5.0 and 410 M

in 0.2 M

sodium acetate buffer, pH 5.0 were used for these calculations; see
section III.l).

Therefore, the spectral changes observed in the

binding studies are the result of an equilibrium between the singly
charged monomeric form of Miracil D and the intercalated form of the
drug.
It should be noted that increasing ionic strength decreases the
extent of binding.

A 27-fold decrease in the intrinsic association

constant was observed going from 0.01 M to 0.2 M sodium acetate buffer,
pH 5.0.

This finding is in agreement with the general trend exhibited

in the binding of other intercalators to nucleic acids (Aktipis and
Kindelis, 1973; Blake and Pecocke, 1968; Waring, 1965).
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-)

Figure 15.

The Scatchard plot of the binding of Miracil D to calf

thymus DNA in 0.2 M sodium acetate buffer, pH 5.0 at room temperature.
The experimentally obtained points are shown together with the calculated isotherm (solid line) for an intrinsic association constant of
4.5x10

4 M-1 •
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III. 2. 2.

The Binding of Miracil D to Calf Thymus DNA under RNA

polymerase Assay Conditions

-

The binding of Miracil D to calf thymus DNA was also investi-

gated under the experimental conditions used for DNA dependent RNA
palymerase assays.

These studies were carried out at 37

°c

and in

the same buffer as the RNA polymerase assays (see section 11.11) with
the exception that bovine serum albumin and dithiothreitol were oPreliminary experiments showed that this omission had no

mitted.

effect on the extent of binding.
The Scatchard plot and the calculated theoretical isotherm determined, using an intrinsic association constant of 1.35x10 4 ~- 1 , are
shown in Figure 16.
,.,.

Comparison of the intrinsic association constants

under these conditions and in 0.01

~sodium

acetate buffer, pH 5.0 (see

section 111.2.1) indicates an 88-fold decrease in the value of the
constant.
l·

;·

This decrease is the result of the concerted effect of

changes in both the ionic strength and the temperature to adjust for
the conditions under which these measurements were carried out.
111.2.3.

The Dependence of the Binding of Miracil D to Calf Thymus

DNA on Temperature
The effect of temperature changes on the binding of Miracil D
to calf thymus DNA were obtained from the measurements of absorbance of
Miracil D-calf thymus DNA complexes at 440 nm as the function of
temperature according to the method outlined in section 11.10.1.

The

'

intrinsic association constants were calculated as outlined in section

f

11.10.3.

~

r..t

tt:

The plot of log

K versus the reciprocal absolute temperature
10

83

Figure 16.

The Scatchard plot of the binding of Miracil D to calf

thymus DNA under RNA polymerase assay conditions at 37 °C (see section
II.11).

The experimentally obtained points are shown together with t

calculated isotherm (solid line) for an intrinsic association constant
of 1.35x104 M-1 •
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. l/T for the binding of Miracil D to calf thymus DNA in 0.01 M sodium
acetate buffer, pH 5.0 is shown in Figure 17.

A linear relationship

was obtained in the temperature range of 25 to 60

0

c.

From the slope

(=2.35) of the plot and from the intrinsic association constant at
0

25

c (1.2x10

6

-1

~

; see section III.2.1), the following thermodynamic

quantities were calculated:
and

~S

0

=-8.2 cal/Mole/K.

~G

0

=-8.2 Kcal/Mole,

0

~H

=-10.7 Kcal/Mole,

These values are correct of course only to

the extent that the activty coefficients can be assumed to be at unity.
Since the absolute value of
(10700 > 298·8.2), and both

~H

0

and

0
~H

.

1s greater than that of

T·~s

0

T·~S

0

have the same sign, it appears

that the unfavourable entropy change, which accompanies the binding
process, is overcompensated by the attending enthalpy change.
Therefore, the binding process is enthalpy-driven.
For a comparison of the thermodynamic quantities presented above
with those characteristic of other intercalators, the binding of
ethidium bromide to DNA in 1

~

NaCl may be considered.

elusion model, Bresloff and Crothers found that
~S

0

~H

o

=-7.72 cal/Mole/K (Bresloff and Crothers, 1975).

Using the ex-

=-7.8 Kcal/Mole and
This binding

process is also enthalpy-driven.
III.2.4.

The Binding of Methyl-Miracil D to Calf Thymus DNA at 0.01

~1

Salt Concentration
The binding of methyl-Miracil D to calf thymus DNA was investigated in 0.01

~sodium

acetate buffer, pH 5.0 at room temperature.

absorption spectra of methyl-Miracil D-DNA complexes in the visible
spectral region (Figure 18) were obtained at constant drug concentration (2x10

-5

~)

as the DNA concentration was varied.

The
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Figure 17.

The van't Hoff plot of Miracil D-DNA binding in 0.01 M

sodium acetate buffer, pH 5.0.
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Figure 18.

The absorption spectra of methyl-Miracil D-DNA complexes

in 0.01 M sodium acetate buffer, pH 5.0 at room temperature obtained
10 em cells.

Methyl-Miracil D concentration: 2x10 -5

trations: (a) 0, (b) 5x10

~

M, (c) 1.2x10

~

~.

DNA concen-

M, and (d) 6.2x10

~

M.
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Free methyl-Miracil D exhibits two absorption maxima at 374 and
425 nm.
~··

Upon addition of DNA, the intensity of both maxima decreases,

and the two bands appear to merge into a single band centered around
410 nm.

The largest changes in absorbance were obtained at 370 and

450 nm.

The absorbances at these wavelengths were, therefore, used in

calculating the intrinsic association constant for the system.
Although no isosbestic point is observed, the absorption
spectra were evaluated with the assumption that only two spectral
species are present in these solutions.

If there were a DNA concen-

tration range in which the spectra of complexes exhibited an isosbestic
point while in another DNA concentration range no isosbestic point
could be observed, this would be a clear indication of the presence of
more than two spectral species.

This is not the case; therefore, the

assumption about the presence of only two spectral species is compatible with the spectra of methyl-Miracil D-DNA complexes (Figure 18).
This reasoning is obviously supportive but not conclusive.
However, the assumption that only two absorbing species are
present is further supported by the finding that the intrinsic association constants determined from the spectral changes at 370 and 450 nm
are in good agreement with one another as it is apparent from examining the values listed below.
The Scatchard plot of the binding of methyl-}liracil D to calf
thymus DNA in 0.01 l1 sodium acetate buffer, pH 5.0 is shown in Figure
19.

The experimental points obtained at 370 nm are shown together with

the calculated theoretical isotherm determined, using an intrinsic association constant of 1. 7x10 5 H-1 •

This constant corresponds to a !1G 0

91

Figure 19.

The Scatchard plot of the binding of methyl-Miracil D to

calf thymus DNA in 0.01 M sodium acetate buffer, pH 5.0 at room temperature.

The experimentally obtained points are shown together with the

calculated isotherm (solid line) for an intrinsic association constant
of 1. 7xl0

5

-1

M •
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5

value of -7.1 Kcal/Mole (=-R·T·ln(1.7x10 )).

The isotherm describes

~.

the binding of methyl-Miracil D to calf thymus DNA on the basis of the
exclusion model, the applicability of which will be discussed in
sections IV.2 and IV.3.
section II.7.

The calculations were performed as outlined in

The same calculations were performed on the experimental

data obtained at 450 nm and an intrinsic association constant of
1.5x10

5

-1
.
5 -1
M was obtained in good agreement w1th a value of 1.7x10 M

obtained from data at 370 nm (see above).
It is reasonable to assume that the pKa of the distal nitrogen
atom of Hiracil D is not much affected by the methyl substitution on
the proximal nitrogen atom.

Therefore, the pKa of the distal nitrogen

atom of methyl-Miracil D should not be much different than 7.4, the
value noted for Miracil D.

In addition, since the pK of the proximal
a

nitrogen atom of methyl-Miracil Dis 3.41, this drug, in analogy to
Miracil D, should carry at pH 5.0 a positive charge on its distal
nitrogen atom.

Assuming that methyl-Miracil D has a dimerization

constant comparable to that of Miracil D, at a concentration of 2x10

-5

M

more than 98 % of the drug should be present as singly charged monomer.

Therefore, the spectral changes observed in the binding studies

are the result of an equilibrium between the singly charged monomeric
form of methyl-Miracil D and the intercalated form of the drug.

An examination of the binding of methyl-Miracil D to calf thymus
DNA under the conditions of RNA polymerase assays was also attempted.
However, extremely large DNA concentrations are required to observe
small spectral changes in the spectrum of methyl-Miracil D under these
conditions.

Since a meaningful association constant cannot be ob-
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tained by the spectrophotometric method used in these

inv~stigations,

an estimation was performed to obtain the intrinsic association
constant which is outlined in section III.5.3.
!1!.2.5.

The Binding of MDMT to Calf Thymus DNA

The binding of MDMT to calf thymus DNA was investigated in 0.01
M sodium acetate buffer, pH 5.0 at room temperature.

In the course of

this investigation, difficulties were encountered in the evaluation of
spectral data because of two reasons.

First, absorbance changes oc-

curing upon addition of DNA are small even at the highest possible
nucleic acid concentrations.

Second, the maximal spectral changes

take place in the 300 to 315 nm region.

In this region, considerable

absorbances are exhibited by DNA especially at high DNA concentrations.
The spectra obtained cross over one another without establishing a
well-defined isosbestic point.

Although this appears to be the result

of limitations in the accuracy with which the DNA absorbances can be
blanked out, the possibility that more than two absorbing species are
present in these solutions cannot be ruled out.
In spite of the difficulties mentioned above, the intrinsic association constant K was estimated by giving arbitrary values to the
absorbance Ab of DNA-bound

~IDMT.

The best fitting theoretical iso-

therms were then calculated using the method described in section

U.8.3.

An intrinsic association constant K ranging between 5x10

3

and

Sx10 4 M- 1 was the most compatible with the spectral data as judged by
the standard error of estimate.

Therefore, it appears that the binding

of MDMT to calf thymus DNA in 0.01

~sodium

acetate buffer, pH 5.0 at

room temperature is weaker than that of methyl-Miracil D under similar
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conditions (see section III.2.4).
Circular Dichroism Measurements

I II . 3 .

1JI.3.1.

The Miracil D-DNA Complex

The circular dichroism of Miracil D-calf thymus DNA complexes
was investigated in 0.01 M sodium acetate buffer, pH 5.0 at room
temperature.

In these measurements, the concentration of Miracil D was

maintained constant at 2x10-5 ~' while the DNA concentration was varied.
The circular dichroism spectra of the complexes are shown in Figure 20.
Miracil D itself is optically inactive, but clearly optical activity is induced upon addition of DNA.

The circular dichroism spectra

in the 300 to 375 nm wavelength region are composed of two overlapping
negative peaks with maxima near 337 and 347 nm.

These maxima appear to

correspond to the absorption maximum of the bound drug at 337 nm and to
the shoulder noted near 352 nm (cf. Figure 12).

The positive circular

dichroism band centered near 447 nm appears to correspond to the absorption maximum of the bound drug at 450 nm.
The dependence of the differential molar extinction coefficient
~-ER

on the binding ratio rat 337, 347, and 447 nm is shown in

Figures 21, 22, and 23.

The concentration of Miracil D bound to DNA

was calculated on the basis of an association constant of 1.2x10 6 M-l
(see section III.2.1).

At all three wavelengths, the differential

molar extinction coefficients decrease with increasing binding ratio.
Since the circular dichroism bands with maxima near 337 and 347 nm
partially overlap, EL-ER values at these wavelengths are calculated
with the understanding that they are overestimated.
The circular dichroism of Miracil D-calf thymus DNA complexes
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Figure 20.

The circular dichroism spectra of Miracil D-DNA complexes

in 0.01 M sodium acetate buffer, pH 5.0 at room temperature in 10 em
cells.

Miracil D concentration: 2xl0

(b) 3x10-5 M, (c) 7.6x10 ~

~'

-5

~,

DNA concentrations: (a) 0,

and (d) 3xl0 ~ M.

(b) 0.22, (c) 0.20, and (d) 0.065.

Binding ratios:
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Figure 21.

The dependence of the differential molar extinction coef-

ficient EL-ER of Miracil D-DNA complexes at 337 nm on the binding
r in 0.01 M sodium acetate buffer, pH 5.0 at room temperature.
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Figure 22.

The dependence of the differential molar extinction coef-

ficient EL-ER of Miracil D-DNA complexes at 347 nm on the binding ratio
r in 0.01 M sodium acetate buffer, pH 5.0 at room temperature.
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Figure 23.

The dependence of the differential molar extinction coef-

ficient EL-ER of Miracil D-DNA complexes at 447 nm on the binding
r in 0.01 M sodium acetate buffer, pH 5.0 at room temperature.
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also investigated in 0.2 M sodium acetate buffer, pH 5.0 at room

temperature. Because of the lowered intrinsic association constant
under these conditions relative to that in 0.01 M sodium acetate
buffer, pH 5.0 (see section III.2.1), a range of binding ratios from
o.05 to 0.11 was studied.

The spectra obtained under these conditions

are similar to those in Figure 20 in their overall character and in the
location of bands.

The differential molar extinction coefficient EL-ER

at 337, 347, and 447 nm decreases with increasing binding ratios, and
the numerical values of EL-ER are essentially the same as those of
Miracil D-calf thymus DNA complexes in 0.01 M sodium acetate buffer,
pH 5.0 (Figures 21, 22, and 23).
III.3.2.

The Methyl-Miracil D-DNA Complex

The circular dichroism of methyl-Miracil D-calf thymus DNA
complexes was investigated in 0.01 M sodium acetate buffer, pH 5.0 at
room temperature.

In these measurements, the concentration of methyl-

Miracil D was maintained constant at 2x10 -5 M, while the DNA concentration was varied.

The circular dichroism spectra of the complexes

are shown in Figure 24.
In analogy with Miracil D, methyl-Miracil D itself is optically
inactive, but optical activity is induced upon association with DNA.
The positive circular dichroism maximum at 405 nm appears to correspond
to the absorption maximum of the bound drug at 410 nm (cf. Figure 18).
The negative circular dichroism maximum at 335 nm and the shoulder at
353 nm correspond to the barely distinguishable shoulders at 335 and
353 nm on the long wavelength tail of the absorption spectrum of the
bound drug.
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Figure 24.

The circular dichroism spectra of methyl-Miracil D-DNA

complexes in 0.01 M sodium acetate buffer, pH 5.0 at room temperature
in 10 em cells.

Methyl-Miracil D concentration: 2x10-S M, DNA concen-

4
trations: (a) 0, (b) lxl0-4 M, (c) 4xl0- M.
and (c) 0.048.

Binding ratios: (b) 0.14
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The dependence of the differential molar extinction coefficient
~-ER

on the binding ratio r at 335, 353, and 405 nm is shown in

Figures 25, 26, and 27.

The concentration of methyl-Miracil D bound to

DNA was calculated on the basis of an association constant of 1.7x105
M- 1 (see section 111.2.4).

In general, the differential molar ex-

tinction coefficients in this system are significantly lower than those
characteristic of the Miracil D-DNA complexes, but their dependences on
the binding ratio r are of similar character.
III.3.3.

The MDMT-DNA Complex

The circular dichroism of MDMT-calf thymus DNA complexes was
investigated in 0.01 M sodium acetate buffer, pH 5.0 at room temperature.

As is the case with Miracil D and methyl-Miracil D, }IDMT is

optically inactive.

At a drug concentration of 2x10-5 M and the

highest practical nucleic acid concentration of 4x10-4 ~. no optical
activity could be detected in the wavelength region between 300 and 600
nm.

This finding suggests that either the complex formed is optically

inactive or that it may be formed at such low concentrations that even
if it were active, the circular dichroism would be below the sensitivity limits of the instrumentation.
III.4.

Hyperchromicity and Circular Dichroism Measurements at Ele-

vated Temperatures
111.4.1.

Hyperchromicity of the Miracil D-DNA and Methyl-Miracil D-

DNA Complexes
The effect of Miracil D and its methyl derivative on the stability of calf thymus DNA against heat denaturation was investigated in
0.01 M sodium acetate buffer, pH 5.0.

The melting profiles at 260 nm
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Figure 25.

The dependence of the differential molar extinction coef-

ficient EL-ER of methyl-Miracil D-DNA complexes at 335 nm on the
binding ratio r in 0.01 M sodium acetate buffer, pH 5.0 at room temperature.
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Figure 26.

The dependence of the differential molar extinction coef-

ficient EL-ER of methyl-Miracil D-DNA complexes at 353 nm on the
binding ratio r in 0.01 M sodium acetate buffer, pH 5.0 at room
ature.
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Figure 27.

The dependence of the differential molar extinction coef-

ficient EL-ER of methyl-Miracil

D~DNA

complexes at 405 nm on the

binding ratio r in 0.01 M sodium acetate buffer, pH 5.0 at room temperature.
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are presented in Figures 28 and 29.

The melting temperatures at

different drug concentrations are summarized in Table I.

Both drugs

increase the melting temperature of DNA, but Miracil D is more effective in this respect than its methyl derivative when the comparison
is made on the basis of total drug concentrations present in these solutions.

An interesting feature of these melting profiles is the slow

increase in normalized hyperchromicity noted with increasing temperature prior to DNA melting.

Similar behaviour was observed in the case

of aminoacridines, and the effect was assigned to the release of drug
from the drug-DNA complex prior to melting (Gersch and Jordan, 1965).
Both Miracil D and its methyl derivative are reported to increase the Tm of calf thymus DNA in 0.33
pH 6.8, containing 3

~

~

sodium phosphate buffer,

NaCl and 0.1 mM EDTA (Hirschberg et al., 1968).

At drug concentrations of 5x10- 6 M and calf thymus DNA concentration
of 5.8x10-5 M, the increases in Tm are 13 and 3

0

C, respectively (the

ratio of total drug concentration to DNA concentration is about 0.086).
For the comparison of these reported increases in the melting temperature with our results, complexes with drug concentration of 10-5 M
and DNA concentrations of 1.66x10-4 M were selected (the ratio of total
drug concentration to DNA concentration is 0.06).

The purpose of this

selection was to have the ratios of total drug concentrations to DNA
concentrations for the reported complexes and our complexes as close as
possible.

In this case Miracil D and methyl-Miracil D cause 13.5 °C

(=71-57.5, see Table I) and 6 °C (=63.5-57.5, see Table I) increase in
the melting temperature, respectively.

While the agreement between

the reported values and our results is excellent for Miracil D, methyl-
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Figure 28.

The dependence of the normalized hyperchromicity h

n

of calf

thymus DNA (a) and Miracil D-calf thymus DNA complexes (b, c, and d) at
260 nm on the temperature in 0.01 M sodium acetate buffer, pH 5.0 and
1 em cell.

DNA concentration: 1.66x10-4 M, Miracil D concentrations:

(a) 0, (b) 1x10

~

M, (c) 2x10

~

M, and (d) 5x10

(b) 0.059, (c) 0.117, and (d) 0.219.
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Figure 29.

The dependence of the normalized hyperchromicity h

calf thymus DNA (a) and

methyl~Miracil

n

of

D-calf thymus DNA complexes

(b and c) at 260 nm on the temperature in 0.01 M sodium acetate buffer,
pH 5.0 and 1 em cell.

DNA concentration: 1.66xl0-4 M, methyl-Miracil D

concentrations: (a) 0, (b) 1x10
(b) 0.051 and (c) 0.170.

-5 M, and (c) 5x10-5 M.

Binding ratios:

r
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Table I
The effect of Miracil D and methyl-Miracil D on the thermal
stability of calf thymus DNA (1.66xl0-

4

M) in 0.01 M sodium acetate

buffer , pH 5 • 0.

Drug

Profile
obtained
at

Concentration of added drug, M

0

10-5

2x10- 5

5x10-5

77 oc

84 °C

Miracil D

260 nm*

57.5 °C

71 °C

Methyl-Miracil D

260 nm*

57.5 °C

63.5 °C

Miracil D

440 nm** 57.5 oc

74 oc

Methyl-Miracil D

440 nm** 57.5 oc

63.5 °C

* Melting ,temperature Tm
** Drug-DNA dissociation transition temperature

71.5 °C
78 °C

84 oc
71.5 °C
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Miracil D proved more effective in our study than previously reported
(Hirschberg et al., 1968c).

This increased effectiveness is under-

standable in the view of the considerations presented in the following
section (see section III.4.3).
Both

~Uracil

D and methyl-Miracil D absorb light at 440 nm and

the free drugs exhibit larger extinction coefficients at this wavelength than the DNA-bound drugs.

DNA does not absorb light at 440 nm.

Therefore, changes in the absorbance at this wavelength are proportional to the amount of drugs released from the drug-DNA complexes, and
can be used to quantitate the extent of binding of drugs to DNA.

A

similar approach has been used to investigate the proflavine-DNA and
acridine orange-DNA systems (KleinwHchter et al., 1969).
The dependence of the normalized absorbance change AA at 440 nm
n
on the temperature is presented in Figures 30 and 31, and the drug-DNA
dissociation transition temperatures are summarized in Table I.

It can

be seen from Table I that the melting temperatures and the drug-DNA
dissociation transition temperatures do not coinc"ide for Miracil D for
both concentrations of 10-5 and 2x1o- 5 M.

This is a good indication

that Miracil D is released from the complex in the later stages of DNA
melting.
This observation is understandable in the view of the reintercalation model proposed by Lazurkin and his coworkers (Lazurkin et al.,
1970).

According to this model, the least stable regions of the double

helix of the drug-DNA complex will dissociate first causing the release
of drug molecules from this region.

This produces a decrease in the

effective PNA concentration so that the pool of free drug molecules in-
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Figure 30.

The dependence of the normalized absorbance change

~A

n

of

Miracil D-calf thymus DNA complexes at 440 nm on the temperature in
0.01 M sodium acetate buffer, pH 5.0 and 1 em cell.
1.66x10

-4

DNA concentration:

-5
-5
M, Miracil D concentrations: (a) 1x10
M, (b) 2x10
M, and

(c) 5xl0- 5 M.

Binding ratios: (a) 0.059, (b) 0.117, and (c) 0.219.
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Figure 31.

The dependence of the normalized absorbance change

~A

n

of

methyl-Miracil D-calf thymus DNA complexes at 440 nm on the temperature
in 0.01 M sodium acetate buffer, pH 5.0 and 1 em cell.

DNA concen-

tration: 1.66x1o-4 M, methyl-Miracil D concentrations: (a) 1x1o-5 M and
(b) 5x1o-5 M.

Binding ratios: (a) 0.051 and (b) 0.17.
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creases beyond the free drug concentration dictated by the law of mass
action.

Therefore, drug molecules bind to those intact regions of DNA

molecule which are not saturated with drug molecules so as to reestablish the equilibrium.

The overall effect is that the release of

drug from the complex lags behind the process of the dissociation of
the double helix, unless the DNA is completely saturated with the drug
before the onset of melting.

Similar conclusions have been drawn about

the ethidium bromide-DNA complex (Aktipis et al., 1975).
The effect of ionic strength on the stabilization of calf thymus
DNA against heat denaturation by Miracil D and methyl-Miracil D was
investigated in 0.01
0.075 M NaCl.

~sodium

acetate buffer, pH 5.0, containing

The melting temperature of DNA under this condition is

found to be 81 °C, contrasted with the value of 57.5 °C in the absence
of sodium chloride (see Table I).

This increase of T is the result of
m

the decreased electrostatic repulsion between the phosphate groups of
DNA in the presence of salts (Schildkraut and Lifson, 1965).

At a

total drug concentration of 10- 5 M and DNA concentration of 1.66x10-4 M,
Miracil D increased the metling temperature of DNA by 2 °C, while
methyl~iracil

D had no effect at all (the corresponding values in the

absence of sodium chloride are 13.5 and 6 °C, respectively; see text
above).
111.4.2.

Circular Dichroism Measurements at Elevated Temperatures

Clearly as a result of drug reintercalation {see preceding
section), the binding ratio r for the intact regions increases as the
melting process is propagated.

Since the differential molar extinction

coefficient EL-ER is dependent on the binding ratio, it was of interest
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to investigate the dependence of E1 -ER of Miracil D-DNA complexes as
the temperature is increased.
III.4.2.1.

Miracil D-DNA Complex at Low Binding Ratios

The dependence of the normalized absorbance change bAn of the
Miracil D-DNA complex on the temperature (Figure 32, curve a) suggests
that no drug is released from the complex for temperatures lower than
55 °C.

This is not surprising since uncle~ these conditions the DNA is

far from being saturated (r=0.059 at 25 °C) and the intrinsic association constant remains within a fairly narrow range (1.2x106 ~- 1 at
25

0

C, see section III.2.1, and 2.2x10

van't Hoff plot, see section III.2.3).

5

-1

M

at 55

0

C, obtained from the

However, over the same tempera-

ture range the differential molar extinction coefficient E -ER de1

creases by about 20% (Figure 32, curve b), apparently due to gradual
conformational change in the complex.

This probably results from a

modification of the electronic and magnetic interactions which produce
changes in the rotational strength.

The rate of the change in E1 -ER in

this temperature range is -2.8x10- 2 liter•Mole- 1 ·cm- 1 •°C- 1 •
Above 55 °C, however, Miracil D is continuously released from
the complex with increasing temperatures as suggested by the increases
noted in the normalized absorbance change (Figure 32, curve a).

The

rate of the change in E1 -ER in this temperature range is -7.8xl0liter•Mole -1 •em-1 • 0 C-1 , i.e. 2.8 times faster than below 55

0

C.

2

This

increased rate appears to be the result of the gradual conformational
changes noted below 55 °C (and continued at temperatures over 55 °C)
and the reintercalation of Miracil D (see section III.4.1) which occurs
during the course of the melting process.

Assuming that the rate of
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Figure 32.

The dependence of (a) the normalized absorbance change AA

n

at 440 nm, (b) the differential molar extinction coefficient EL-ER at
347 nm, and (c) the differential molar extinction coefficient EL-ER
corrected for conformational changes at 347 nm (dashed line, see text
for details) on the temperature of Miracil D-eal£ thymus DNA
0.01 M sodium acetate buffer, pH 5.0 and 1 em cell.
8.4x10- 4 M and Miracil D concentration: 5x10-S M.
ditions the binding ratio r is 0.059 at 25 °C.

DNA concentration:
Under these con-

yo-

0
0

0
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EL-~

the change in

due to conformational change in the complex below

55 °C is maintained for temperatures above 55 °C, the experimentally

observed differential molar extinction coefficient EL-ER can be adjusted so as to obtain EL-ER values, the changes of which may represent the reintercalation of Miracil D during melting.
~-ER

The corrected

curve is presented in Figure 32 (curve c, dashed line), which was

constructed by drawing a tangent to curve b (Figure 32) at 55 °C with a
slope of 5x10

-2

liter•Mole

-1

-1 0 -1
-2
-2
•em • C
(=7.8x10 -2.8x10 ).

Thus the corrected EL-ER curve may represent the change in circular dichroism due simply to reintercalation of

~uracil

D.

At the onset

of DNA melting (around 55 °C), the binding ratio of the complex is about
0.059 (no drug is released between 25 and 55 °C).

Between 55 and 90 °C

the corrected EL-ER values decrease by a factor of 2.5.

A decrease in

EL-ER values by the same factor of 2.5 is obtained if the binding ratio
is increased from 0.059 to 0.23 using data on the dependence of the
differential molar extinction coefficient on the binding ratio (Figure
22).

A ratio of 0.23 is obtained by the end of the melting process,

i.e. around 90

0

C.

Since at the point of saturation the binding ratio

is 0.25, a binding ratio of 0.23 indicates that· at the end of the
melting

p~ocess

111.4.2.2.

the DNA is almost completely saturated with Miracil D.

Miracil D-DNA Complex at High Binding Ratios

For a Miracil D-DNA complex in which the DNA is almost saturated by the drug at room temperature (i.e. r=0.22 at 25 °C), therelease of drug occurs at lower temperatures so that both the release and
the decrease of differential molar extinction coefficient EL-ER are initiated concurrently at 25 °C (Figure 33, curves a and b).

The EL-ER is
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linearly dependent on the temperature in the whole temperature range
studied, including the melting region (from 80 to 90 °C, see Figure 33,
curve b) of DNA.
em

-1

0

-1

• C

.

The rate of change in EL-ER is -2.2xl0 -2· liter•Mole -1 •

The constancy of this rate throughout the whole temperature

range, including the melting region of DNA, suggests that the same
process takes place in the course of DNA melting as prior to DNA
melting (below 80

0

C).

Furthermore, the similarity of this rate of

change in EL-ER to that of a Miracil D-DNA complex of low binding
ratios prior to melting (-2.8x10 -2 liter•Mole -1 •em-1 • 0 C-1 , see preceding
section) suggests that the conformational change which takes place in
the whole temperature range studied is not accompanied by reintercalation and, therefore, is a change analogous to that which takes place
with Miracil D-DNA complex at low binding ratios and below 55 °C.

This

finding is in agreement with expectation, since the DNA is almost saturated with the drug at room temperature, and consequently there are no
free binding sites for reintercalation.
The results presented here and the preceding section are quite
convincing in favour of the operation of the reintercalation process in
the Miracil D-DNA system.

It should be also noted that in order for re-

intercalation to take place, the rate of the change of the intrinsic association constant with temperature in the melting region must be
smaller than the rate of DNA denaturation.
fulfilled for Miracil D.

This requirement seems to be

However, inspection of the melting tempera-

tures (at 260 nm) and the corresponding drug-DNA dissociation transition
temperatures (at 440 nm) of methyl-Miracil D-DNA complexes (see Table I)
indicates that reintercalation does not take place ( the temperatures at
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Figure 33.

The dependence of (a) the normalized absorbance change 6A
n

at 440 nm and (b) the differential molar extinction coefficient EL-ER
at 347 nm on the temperature of Miracil D-eal£ thymus DNA complex in
0.01 M so~ium acetate buffer, pH 5.0 and 1 em cell.
1.68xl0-4 M and Miracil D concentration: 5x10-5 M.
ditions the binding ratio r is 0.22 at 25 °C.

DNA concentration:
Under these con-
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the two wavelengths are identical).

It is possible,

ther~fore,

that

the above requirement is not satisfied in the case of methyl-Miracil DDNA system.
III.4.3.

Stabilization of the DNA Helix by Miracil D and Methyl-

Miracil D
Because of the dissociation of drugs from the drug-DNA complexes
at elevated temperatures, the binding ratios of these complexes are
clearly smaller at the onset of DNA melting than they are at 25 °C.

As

melting progresses, however, the binding ratio of the intact regions
increases rather than decreases
!11.4.1 and III.4.2).

du~

to reintercalation (see sections

In order to compare each drug with respect to

its effectiveness in stabilizing the double helix, the state of the
complex at the melting temperature at 260 nm was chosen for the
standard state of the complex.

At this temperature, 50 % of the binding

sites are assumed to be denatured, meaning that the effective nucleic
acid concentration at these temperatures is half of that at 25 °C.

The

binding ratios at these temperatures were obtained from the binding
ratios at 25 °C and the observed normalized absorbance changes at 440
nm.

The difference 6Tm between the melting temperatures in the

presence and absence of drug measures the degree of stabilization
caused by each drug.

The results of these calculations are summarized

in Table II, and the dependence of stabilization bTm on the binding
ratio at the Tm of the drug-DNA complex is presented in Figure 34.
Surprisingly, a linear relationship is obtained, and the experimental points for both Miracil D and methyl-Miracil D fall on the same
line.

Consequently, the drugs, when bound to DNA, appear to stabilize

Table II
The extent of thermal stabilization (6Tm) of calf thymus DNA by Miracil D and methyl-Miracil D
in 0.01 M sodium acetate buffer, pH 5.0 and the binding ratios of Miracil D-DNA and methylMiracil D-DNA complexes at the melting temperatures (at 260 nm).

T of DNA
(~60 nm),
oc

Miracil D

T of drug- StabiliDWA complex
zation
(260 nm) , °C
8Tm' °C

r
(at 25 °C)

r
(at T of
complfex)

8An
(at T of
complfex)

57.5

71

13.5

0.059

0.32

0.080

57.5

77

19.5

0.110

0.52

0.110

57.5

84

26.5

0.220

0.64

0.160

57.5

63.5

6

0.051

0.65

0.036

57.5

71.5

14

0.170

0.74

0.088

Methyl-Miracil D

The values of r at Tm of the drug-DNA complexes were calculated according to the equation
r(at Tm of complex)=2•r(at 25 °C)•[1-8An (at Tm of complex)]

.

w

~
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Figure 34.

The effectiveness of Miracil D (e) and methyl-Miracil D

in stabilizing calf thymus DNA in 0.01
against heat denaturation.

~sodium

acetate

buffer~

<•>

pH 5.0

Binding ratios of drug-DNA complexes at the

melting temperatures are indicated in the abscissa.
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calf thymus DNA equally well.

Therefore, previously reported data

which indicate that Miracil D is much more effective in stabilizing
calf thymus DNA against heat denaturation (Hirschberg et al., 1968c)
than its methyl derivative are the result of the differences in the
binding characteristics of these two compounds.
III.S.

The Inhibition of RNA Synthesis by Thioxanthenones

III.5.1.

The RNA Synthesis Assay at pH 7.0

Assays of RNA synthesis by DNA dependent RNA polymerase in the
literature are .generally carried out at pH 8.0, which is the pH optimum of the enzyme (Chamberlin and Berg, 1962).

However, because of the

very limited solubility of Miracil D at pH 8.0 and the difficulties in
preparing soluble Miracil D-DNA complexes at this pH, the investigations on the inhibition of DNA dependent RNA polymerase by Miracil D,
methyl-Miracil D as well as MDMT were carried out at pH 7.0.

At this

pH, the enzymic activity is 62 % of its maximum value (Chamberlin and
Berg, 1962).
In order to establish the conditions for the reaction at pH 7.0,
the synthesis of RNA as a function of reaction time was first investigated using calf thymus DNA as template (Figure 35).

The reaction is

linear with time for the first 8 minutes, and then it slows down appreciably.

The time course of the reaction follows roughly first order

kinetics, and the decrease in the rate of RNA synthesis cannot be accounted for simply by substrate depletion.

The cessation of RNA synthe-

sis after long reaction times is not peculiar to the pH conditions used
for the assay, since similar kinetics have been observed under a variety of conditions (Hurwitz et al., 1962; Kozlov, 1971).

A reaction time
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Figure 35.

The kinetics of RNA synthesis.

Enzyme concentration:

7.9 units/ml and calf thymus DNA concentration: 30

~g/ml.
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of 8 minutes was selected in all subsequent assays for which a calf
thymus DNA template was used.

When using T2 bacteriophage DNA as

template, the rate of RNA synthesis was constant in the first 10
minutes of the synthesis.
The dependence of RNA synthesis on the concentration of calf
thymus DNA was also investigated, and the results are presented in
Figure 36.

Although the plot resembles the usual Michaelis-Menten

hyperbolic relationship, the corresponding Lineweaver-Burk plot does
not yield a straight line.

The concentration of calf thymus DNA, at

which half of the maximum incorporation is obtained, is about 10
This value is in contrast to 4.8

~g/ml

~g/ml.

reported at pH 7.5 {Hurwitz et

al., 1962).
For the inhibition studies using calf thymus DNA as template, a
DNA concentration of 23

~g/ml

was selected.

This value represents a

compromise between two counteracting requirements: a template concentration small enough to be rate limiting, but large enough to produce
significant incorporation of radioactive label.
III.5.2.

The Inhibition of RNA Polymerase by Miracil D, Methyl-

Miracil D, and MDMT
The inhibition of DNA dependent RNA polymerase by Miracil D,
methyl-Miracil D, and MDMT was investigated under the experimental conditions described in the preceding section.

The experiments were per-

formed as outlined in section II.11, and the results are presented in
Figures 37 and 38.
It is apparent that all three drugs inhibit RNA synthesis.
Methyl-Miracil D and MDMT appear to be equally effective when compared
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Figure 36.

The dependence of RNA syntheis on the template (calf thymus

DNA) concentration.

Enzyme concentration: 7.6 units/ml.
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Figure 37.

The inhibition of RNA synthesis by Miracil D.

Enzyme concen-

tration: 10 units/ml, calf thymus DNA concentration: 23 pg/ml, and
nucleoside triphosphate concentration: 0.5 mM (each).
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Figure 38.

The inhibition of RNA synthesis by methyl-Miracil D (e)

and MDMT (.A).

Enzyme concentration: 10 units/ml, calf thymus DNA

concentration: 23 llg/ml, and nucleoside triphosphate concentration:
0.5 mM (each).
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on the basis of the total concentration of drugs present in these solutions (Figures 38).

In contrast, Miracil Dis an order of magnitude

more effective {Figure 37) than the two other derivatives.
This difference between Miracil D and its methyl derivative was
expected in view of the results of an earlier investigation (Hirschberg
et al., 1968c).

Using a similar test system, Hirschberg and his co-

workers -reported that Miracil D causes a 90 % inhibition of RNA polymerase activity, while methyl-Miracil D is completely ineffective at a
drug concentration of SxlO -5 M.

The minor quantitative differences be-

tween these reported results and the results of the present investigation may be due to the differences in assay conditions.

Hirschberg

and his coworkers used salmon sperm DNA at a concentration of 70
in contrast to calf thymus DNA of 23

~g/ml.

~g/ml,

Also the assay was per-

formed at pH 7.9, in contrast to a pH 7.0 used for the present experiments.
The above comparison of Miracil D and methyl-Miracil D with respect to their effectiveness as inhibitors of RNA polymerase is obviously based on total drug concentrations.

However, since Miracil D and

its methyl derivative bind to DNA to different extents, the observed
differences toward RNA polymerase may be apparent rather than real and
could simply be the result of the different binding capacity of these
drugs to DNA.
III.S.3.

Comparison of the Effectiveness of Miracil D and Methyl-

Miracil D to Inhibit RNA Synthesis
As noted in the previous section, the observed apparent differences in the effectiveness of Miracil D and its methyl derivative in in-
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hibiting RNA synthesis may be the result of the differences in their ability to bind to DNA.

In order to make the proper comparison, the

inhibition caused by the drugs should be determined as a function of
bound drug concentrations rather than total drugs present in the assay
mixtures.

This treatment obviously requires knowledge of the intrinsic

association constants of drugs with DNA under the conditions of RNA
polymerase assays.
As noted previously (see section III.2.4), the binding of
methyl-Miracil D to calf thymus DNA under the conditions of RNA synthesis cannot be accurately determined by the spectrophotometric method
used in this investigation.

However, this binding can be estimated in-

directly from absorbance measurements (Figure 30, curve c) carried out
in 0.01 M sodium acetate buffer, pH 5.0 using the method outlined in
section II.10.3.

Under these conditions, it can be calculated that the

intrinsic association constant K for methyl-Miracil D decreases 5.7fold from 1.7x10
37 °C.

5

to 3x10

4

M-

1

as the temperature increases from 25 to

Also from absorbance measurements in 0.01 M sodium acetate

buffer, pH 5.0 at ionic strengths of 0.01 and 0.07 M (adjusted by the
addition of 1M KCl solution), it is estimated that the intrinsic association constant Kat 25 °C decreases 34-fold from 1.7x10 5 to 5x10 3
M- 1 as a result of the increase in ionic strength.

Since no binding

whatsoever can be detected at an ionic strength of 0.2 M, the value of
5x10 3 M-1 may be assumed to be the upper limit for the association
constant at an ionic strength of 0.2 M.

If the effects of temperature

and ionic strength are asssumed to be additive, then the intrinsic association constant of the binding of methyl-Miracil D to calf thymus DNA
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5
under assay conditions cannot be greater than 1.7x10 /(34x5.7)=
8.8x10

2 M-1 •
Using the directly obtained value of 1.35x10 4 ~-

1

for the in-

trinsic association constant of the binding of Miracil D to calf thymus
DNA under assay conditions (see section III.2.2) and the value of
8.8x10 2 M- 1 for the estimated intrinsic association constant of the
binding of methyl-Miracil D to calf thymus DNA under assay

conditions~

the bound drug concentrations and the binding ratios under the conditions of the .assay can be calculated as outlined in Appendix B.

The

synthesis of RNA as a function of the binding ratios for Miracil D and
its methyl derivative are presented in Figure 39.

Clearly, both

Miracil D and methyl-Miracil D, when bound to DNA, inhibit RNA synthesis with equal effectiveness.

It may also be noted that the observed

inhibitory behaviour of the bound forms of the two drugs parallels
their effectiveness in stabilizing DNA against heat denaturation (see
section III.4.3).

This. parallelism of the drugs in the two test systems

is further discussed in section IV.S.
III.5.4.

Miracil D: An Inhibitor of RNA Chain Initiation and

Elongation
In the enzymatic synthesis of RNA, there are four major steps
(Chamberlin, 1974, see section I.6.3): template binding, RNA chain initiation, RNA chain elongation, and termination.
exert its effect on any of these steps.

An inhibitor can

It has been shown that the re-

ciprocal initial velocity 1/vi of the overall reaction (as determined
in the present experiments by 3H incorporation) is linearly dependent
on the binding ratio r, if only the elongation step is inhibited (Hyman
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Figure 39.

The inhibition of RNA synthesis by Miracil D (e) and methyl- )

Miracil D (0) as the function of the binding ratio r.

Enzyme concen-

tration: 10 units/ml, calf thymus DNA concentration: 23 pg/ml, and
nucleoside triphosphate concentration: 0.5 mM (each).
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and Davidson, 1970).

For,Miracil D and its methyl derivative, the de-

pendence of the reciprocal initial velocity 1/v. on the binding ratio
~

r is shown in Figure 40.

In the

ra~ge

of binding ratios from 0 to 0.05

a linear relationship is obtained, indicating that the kinetics of
inhibition are compatible with the inhibition of the elongation step.
At binding ratios greater than 0.05, however, deviations from
linearity are observed.

In order to determine whether these deviations

are a consequence of inhibition of the initiation of RNA synthesis,
the incorporation of both

32

P and

bacteriophage DNA as the template.

3
H in RNA were investigated using T2
Since an RNA molecule retains the

y-phosphate group of the first nucleotide residue involved in its
synthesis, the incorporation of y-[ 32 P]-ATP measures the number of RNA
chains synthesized starting with ATP (Richardson, 1973).

In contrast,

the incorporation of ring labeled [ 3H]-UTP measures the total amount of
RNA synthesized.

Preliminary experiments indicated that the rate of

RNA synthesis using T2 DNA as template is constant for at least 10
minutes of incubation.
In the case of Miracil D, it is apparent (Figure 41) that the
reciprocal initial velocity 1/vi of the total RNA synthesis increases
with r up to a binding ratio of about 0.05.

At higher r values, the

reciprocal initial velocity increases much more rapidly.

The incorpo-

ration of 32 P label, however, remains constant for r values lower than
0.05, indicating that Miracil D does not inhibit initiation.

Clearly,

the same number of chains is synthesized regardless of the concentration
of the inhibitor.
incorporation of

For binding ratios greater than 0.05, however, the
32

P label decreases somewhat.

This is an indication
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Figure 40.

The dependence of the reciprocal initial velocity 1/v

1

of

RNA synthesis on the binding ratio r in the presence of Miracil D (e)
and methyl-Miracil D (0).

Enzyme concentration: 10 units/ml, calf

thymus DNA concentration: 23
tration: 0.5 mM (each).

~g/ml,

and nucleoside triphosphate concen-
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Figure 41.

The dependence of the reciprocal initial velocity 1/v. (e)

and of the initiation

1

<•)

the presence of Miracil D.

of RNA synthesis on the binding ratio r in
Enzyme concentration: 20 units/ml, T2 DNA

concentration: 10 pg/ml, and nucleoside triphosphate concentration:
0.5 mM (each).
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that at higher binding ratios Miracil D interferes also with the initiation step of RNA synthesis.

It seems likely, though no experi-

ments were conducted, that methyl-Hiracil D behaves similarly.
A good correspondence in the dependences of the reciprocal initial velocity on the binding ratio may be noted for T2 DNA and calf
thymus DNA shown in Figures 40 and 41.

Deviations from linearity

start at binding ratios of about 0.05 for both templates.

CHAPTER IV
DISCUSSION
IV.l.

The Structure of the Miracil D-DNA Complex
The binding of Miracil D to DNA takes place through an interca-

lation process as a result of which the drug becomes inserted between
adjacent base pairs of DNA {see section !.6.2).

As the case is with

other intercalators, the major forces stabilizing the complex are
probably the result of dipole-dipole, dipole-induced dipole, and
fluctuation dipole-induced dipole {dispersion forces of London) interactions between the planar aromatic Miracil D molecule and the DNA base
pairs (Gersch and Jordan, 1965).

Maximum stabilization by dispersion

forces is obtained when the overlapping of molecular orbitals of the
drug and the bases is maximal.

This requirement is satisfied only with

the proposed model of Miracil D-DNA complex (Weinstein and Hirschberg,
1971) in which the long axis of the Miracil D molecule is parallel
with those of the base pairs forming the binding site.

In this complex

the electrostatic interactions between the side chain of the drug and
the phosphate backbone of DNA are well-accomodated (see section !.6.2),
but the dipole-dipole interactions are not necessarily at their maximum.

Since the dipole moment vectors of the four bases forming the

binding site and of the intercalated Miracil D molecule show into five
different directions, it is hard to predict whether stabilization or
destabilization by dipole-dipole interactions takes place.
It has been shown in the case of proflavine-DNA complexes
158
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(Gersch and Jordan, 1965) that permanent dipole moments do not seem to
play a decisive role in the orientation of the intercalated drug molecule in the binding sites.

Free energy calculations suggest that a

hypothetical rotation of intercalated proflavine causes less than 1
Kcal/Mole fluctuation in the ~G
IV.2.

0

of the intercalation process.

The Binding of Miracil D to DNA- The Exclusion Model
In the analysis for the interaction of drugs with nucleic acids,

certain formulations can serve as useful diagnostic tools in the
testing of specific binding models.

One of the simplest models for the

interaction of small ligand molecules with proteins was developed by
Scatchard (Scatchard, 1949).

According to this model, if the binding

of a ligand molecule to the protein does not influence the binding of
other ligand molecules to the same protein molecule, then the binding
isotherm has the following form:
r

----=n·k-k·r
cf
where r is the binding ratio as previously defined, k is the intrinsic association constant, and n is the number of binding sites for
the ligand on the protein molecule.

In the Scatchard plot, this iso-

therm represents a straight line with a slope of -k and with an intercept of n·k.

The intercept with the r axis is n.

The same approach can be used for the interaction of drug molecules with nucleic acids.

In this case the nucleic acid concentration

is generally expressed as nucleic acid phosphorous concentration, and,
therefore, the intercept with the r axis gives the number of binding
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sites for the drug per nucleic acid phosphorous.

If all potential

intercalating sites were to bind drug molecules, the number of binding
sites would be 0.5 per DNA phosphorous.
ized.

In practice this is not real-

Scatchard plots for drug-nucleic acid interactions take a varie-

ty of forms, most often not linear, and the number of binding sites is
much less than 0.5, generally ranging between 0.15 and 0.25 (e.g.
Waring, 1965; MUller and Crothers, 1968; Peacocke and Skerrett, 1956;
Tubbs et al., 1964). Deviations from linearity are generally observed
at the higher binding ratios.
In order to overcome the obvious difficulties in the interpretation of curved Scatchard plots, and in order to explain the lower
than expected number of binding sites, the exclusion model was introduced (McGhee and von Hippe!, 1974).
in section II.8.3.

This model is discussed in detail

The exclusion model was, therefore, selected for

analyzing the binding of Miracil D to DNA.

The selection of this model

was suggested by the fact that, as the case is with other drugs, at
saturation only half of the potential DNA binding sites are occupied by
Miracil D.
It may be argued that base specificity in binding can also lead
to binding in which less than the maximum of potential binding sites
are able to participate.

In fact, it has been suggested, based on the

ability of Miracil D to inhibit DNA dependent RNA polymerase when synthetic DNA templates are used, that Miracil D has a stronger affinity
toward adenine residues (Wilson et al., 1972b).

Aside from the fact

that this evidence is not at all conclusive, about 25 % of the bases in
calf thymus DNA are adenine, which suggests that each potential binding
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site contains in the average one adenine residue.

Hence any preference

of Miracil D for adenine residue, if at all present, could not limit
the maximum number of binding sites to as low a value as 0.25.
Specificity toward base pairs G-C or A-T could also lead to a
decrease in the number of potential binding sites as evidenced in the
case of actinomycins (MUller and Crothers, 1968).

Although G-C and A-T

base pairs are equally represented in calf thymus DNA, and could be
responsible for the decreased number of binding sites, this is very unlikely based on the observations of Haidle and Mandel (private coml!lunications to Weinstein and Hirschberg, 1971).

These workers tested

the effect of several bacterial DNA's, ranging in base composition from
27 to 69 % G-C content, on their ability to induce spectral shifts in
the spectrum of Miracil D and found no correlation between this

proper~

ty and G-C content.
Exclusion does not appear to result from simple mutual steric
interference between bound drug molecules.

Since intercalation is ac-

companied by the unwinding of the DNA double helix (Waring, 1970), the
conformation of the binding sites adjacent to an already occupied
binding site differs from the conformation of sites surrounded by unoccupied adjacent sites.

A computerized linked-atom modeling system

was developed by Alden and Arnott to examine the stereochemical requirements for intercalation of planar drugs into DNA (Alden and
Arnott, 1975).

All classes of conformational possibilities for ex-

tending the polynucleotide backbone were examined for their ability to
accomodate insertion of a drug into a base-paired region of DNA compatible with adjacent regions of DNA while stacking interactions,
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steric strain, and non-bonded interatomic contact were opt-imized.

One

conformation was found which proved superior to all others in ability
to satisfy these criteria.

This conformation was obtained by the ex-

tension of the backbone by characteristic changes in two torsion angles
to trans values and a change in one sugar puckering to relieve strain
in an adjacent residue.

The turn angle distributed over three poly-

nucleotide residues for this most general mode of interaction is 90
corresponding to a helical unwinding of 18

° for

good agreement with the unwinding angle of 16.4
I.6.2.

~NA.

°,

This value is in

° discussed

in section

It is possible that this conformational change makes the

nearest neighbour sites so stable that binding to them becomes thermodynamically unfavourable.

As an alternative, it is also possible that

binding of drug molecules to nearest neighbour sites imposes such a
restriction on the bond angles that the binding sites cannot undergo
the conformational changes necessary to accomodate the intercalated
drug molecule.

Independent evidence for the exclusion model is also

obtained from X-ray crystallographic studies the results of which have
suggested that in the ethidium bromide-DNA complex the nearest neighbor
binding sites are excluded from binding (Jain et al., 1973).
Under the conditions of the present binding studies (see section
III.2.1), Miracil Dis present as a positively charged monomer (see
section III.1), ,and, therefore, these studies deal with the interaction
of the monomeric form of the drug wi. th DNA.

The intrinsic associ-

ation constant was found to change from 1.2xl0

6

ionic strength is increased from 0.01 to 0.2 M.

to 4.5x10

4

-1
M when the

This drastic decrease

of K is consistent with the structure of the Miracil D-DNA complex pro-
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posed by Hirschberg (see section !.6.2).

In this

complex~

the terminal

nitrogen atom of the side chain interacts with the negative phosphate
backbone of the DNA.

This electrostatic interaction is obviously re-

duced at high ionic strength simply because of the unfavourable competition between the negative phosphate groups and the more numerous
cations of the buffer for the positive distal nitrogen atom.

This is

by no means to say that this electrostatic interaction is completely
Since the ~G 0 's calculated

abolished at an ionic strength of 0.2 M.

for the two intrinsic association constants at 0.01 and 0.2 M salt
concentrations (see section III.2.1) are -8.2 (i.e. -R•T•ln(1.2x10 6 ))
4
and -6.3 (i.e. -R·T·ln(4.5x10 )) Kcal/Mole, respectively, at least 25 %
(i.e. (8.2-6.3)/8.2) of the forces stabilizing the complex in 0.01 M
sodium acetate buffer, pH 5.0 appear to be electrostatic in character.
IV.3.

The Structure of the

Methyl~1iracil

D-DNA Complex

Methyl substitution in Miracil D leads to steric hindrance between the carbonyl oxygen and this substituent, which necessitates the
rotation of the side chain out of the plane of the heterocyclic ring
system (Zilversmit, 1970).

The ring system of methyl~iracil D, how-

ever, remains planar, and there seems to be no reason why the drug
could be prevented from intercalating.

CPK model building of the

methyl-Miracil D-DNA complex shows that intercalation is sterically
possible, although the conformation of the side chain may limit somewhat the depth of drug penetration between the base pairs of the double
helix.

In this conformation, the interaction between the positive

distal nitrogen atom of the drug and the negative phosphate backbone of
DNA appears to be still possible, but it is not as readily achieved as
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with Miracil D.

As a result, the electrostatic interactions involved

are expected to be reduced which could explain the smaller intrinsic
association constant observed for the binding of
DNA.

methyl~iracil

D to

In fact, there is a difference of 1.1 Kcal/Mole (=8.2-7.1) in the

0

AG 's of the binding of Miracil D and methyl-Miracil D to calf thymus

DNA in 0.01 M sodium acetate buffer, pH 5.0 at room temperature {see
sections III. 2.1 and III. 2. 4).

The lowered intrinsic association

constant compared to Miracil D is certainly not incompatible with the
intercalative mode of binding.
The other line of evidence which strongly suggests intercalation
of methyl-Miracil D comes from the similarities in the circular dichroism spectra of the DNA complexes formed with Miracil D and methylMiracil D.

This will be discussed in detail in section IV.4.

As for the applicability of the exclusion model for the binding
of methyl-Miracil D to DNA, similar arguments can be advanced as in the
case of Miracil D (see section IV.2).
IV.4.

The Circular Dichroism of }liracil D-DNA and Methyl-Miracil D-

DNA Complexes
Both Miracil D and methyl-Miracil D are optically inactive compounds but, as expected from their intercalative mode of binding {see
sections IV.1 and IV.3), they become optically active when bound to DNA
(Figures 20 and 24).

The Aependence of their differential molar ex-

tinction coefficients on the binding ratio of the complexes formed
(Figures 21, 22, 23, 25, 26, and 27) deviate from those of the majority of other intercalative dyes and drugs discussed in section 1.7.2.
They deviate from group 1 in that their differential molar extinction
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coefficients vary greatly with the binding ratios, and from group 2
that their differential molar extinction coefficients decrease with increasing binding ratios and at low binding ratios they exhibit the
maximum circular dichroism.

However, 9-aminoacridine resembles the

characteristics of Miracil D and

methyl~iracil

D complexes (Dalgleish

et al., 1969).
Since the distribution of intercalated Miracil D and methylMiracil D molecules on DNA is random (except for the nearest neighbour
sites due to exclusion), the probability of interaction between intercalated drug molecules is at minimum at low r values.

At these r

values, however, the observed differential molar extinction coefficients are at their maximum values rather than being zero (in contrast to that of group 2 compounds, see section !.7.2).

Therefore, the

observed optical activity at low r values is the result of the interaction between these drugs and the

asyrr~etric

DNA binding sites (see

section !.7.2).
As r increases, the probability of interaction between bound
drug molecules increases.

Two proposals have been advanced for the

mechanism of drug-drug interaction in terms of explaining the resulting
optical activity (Dalgleish et al., 1969): (1) exciton interaction between drug molecules mediated through base pairs and (2) alteration of
the conformation of neighbouring binding sites as the result of
binding.

Exciton interactions between identical monomers lead to con-

servative circular dichroism spectra (Brahms and Brahms, 1970).

Since

the circular dichroism extrema of the bound drug molecules are located
at the same wavelengths as the absorption band maxima (see sections
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111.3.1 and 111.3.2), the circular dichroism spectra of these drugs
must be classified as non-conservative.

Therefore, the exciton inter-

action between bound drug molecules, which is responsible for the optical activity of compounds belonging to group 2 (see section 1.7.2)
(Jackson and Mason, 1971), can be ruled out (Aktipis and Kindelis,
1973).

Therefore, the second mechanism seems likely to describe the

circular dichroism characteristics of Miracil D and

methyl~iracil

D.

The progressive binding of increasing numbers of drug molecules in the
vicinity of molecules already bound is expected to alter continuously
the conformation of the complex resulting in the lowered differential
molar extinction coefficients noted at higher r values.
The quantitative, but not qualitative differences between the
circular dichroism of Miracil D-DNA and

methyl~iracil

D-DNA complexes

could be the result of structural differences of these complexes.

As

mentioned earlier, in methyl-Miracil D the rotation of the side chain
relative to the ring systeo limits somewhat the depth of penetration of
the drug between the base pairs of DNA (see section 1V.3).
lead to a less favourable

positioni~g

This could

of the intercalated methyl-

Miracil D molecules in the binding site as compared to Miracil D.
Since circular dichroism is very sensitive toward changes in molecular
conformations, it seems likely that small differences in the positioning of bound drug molecules within the binding site could cause the
observed differences in the resulting differential molar extinction
coefficients.
In the binding of Miracil D and its methyl derivative to DNA,
further drug binding is excluded on the nearest neighbour binding sites
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due to an indirect effect of bound drug molecules (see section IV.2).
This exclusion effect in binding extends to only the nearest neighbour
binding sites.

However, the effect of binding appears to extend to

sites further away than the nearest neighbour sites as evidenced from
the dependence of the differential molar extinction coefficients on the
binding ratio.
In an analogous manner, the binding of actinomycin was shown to
stabilize binding sites against heat denaturation 15 base pairs away
(Burd et al., 1975).
pendence of E -E

L R

Therefore, the exclusion in binding and the de-

on the binding ratio appears to be the result of the

extension of conformational changes beyond the actual site of drug
binding, which means that both binding exclusion and the circular
dichroism properties of these systems are two manifestations of the same
phenomenon.
IV.5.

The Inhibition of RNA Synthesis by '.\liracil D and Methyl-

Miracil D
Miracil D inhibits two steps in RNA synthesis: initiation and
elongation (see section III.5.4).

Below r values of 0.05, only the

elongation of RNA chains is inhibited, but at binding ratios greater
than 0.05, initiation is inhibited as well.
IV.5.1.

The Inhibition of Initiation of

R!~A

Synthesis by Miracil D

and Hethyl-Miracil D
It is not quite clear why inhibition of initiation comes into
play at an r value of 0.05, but some speculation can be advanced.

For

successful initiation to take place, the enzyme must bind to the prorooter region on DNA.

The bound enzyme molecule occupies about 20 con-
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secutive base pairs (Heyden et al., 1975).

l-lith respect to the macha-

nism of recognition, the promoter site is selected by a random association with and dissociation from the DNA molecule rather than by selection of promoter region as a result of a sliding movement of the
enzyme along the template.

In the next step, the enzyme separates the

two strands of the template for a length of seven or eight base pairs
and assumes the active conformation of the enzyme-template complex
(Chamberlin, 1974).

With regard to this strand separation, RNA po-

lymerase belongs to the class of melting proteins (von Rippel and
McGhee, 1972).

Since the drug binding to DNA is a dynamic equilibrium,

drug molecules constantly associate with and dissociate from at rates
reflected by their rate constants.

If drug molecules are bound to the

promoter region, they could interfere with the binding of the enzyme.
It is believed that a minimum of 12 base pairs is required to insure
that a unique sequence of nucleotides (part of the promoter region),
which is unlikely to be generated by random assortment of nucleotides,
is formed so as to establish a recognition site (Thomas, 1966).

Since

drug binding by intercalation unwinds and extends the double helix, it
appears that intercalated drug molecules distort this unique sequence
of 12 base pairs beyond recognition by the enzyme.

Therefore, it seems

that a drug-free recognition region is necessary for selective binding
of the enzyme to the promoter region.

With increasing binding ratios,

the probability that the recognition region is free of drug molecules
obviously decreases.

Inhibition of initiation is thus more likely to

take place at the higher range of r values, as it has been noted experimentally for Miracil D (see section III.6.4).
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In addition to probability considerations, kinetic considerations are also important concerning the inhibition of initiation.

The

equilibrium position in the competition of drug and enzyme for the
recognition region overwhelmingly favours the enzyme-template complex
which is characterized by an association constant of about 1014 M- 1
(Chamberlin, 1974).

Therefore, incubation of drug, template, and

enzyme for longer periods of time and at higher temperatures before the
onset of

ru~A

initiation.

synthesis would be expected to decrease the inhibition of
This has been substantiated for ethidium bromide

(Richardson, 1973).

Conversely, if drug, template, and enzyme are not

incubated before RNA synthesis started, the inhibition of initiation
would increase relative to the incubated assay.

Indeed, actinomycin D,

which is a strong inhibitor of RNA chain elongation (Hyman and Davidson,
1970) and normally does not inhibit initiation, acts as an initiation
inhibitor as well when the drug, the template, and the enzyme are not
incubated for some time before

ru~A

al., 1967; Sentenac et al., 1968).

synthesis is started (Maitra et
Although this possibility was not

investigated, it might, therefore, be expected that Miracil D would
become a more effective inhibitor of initiation if the incubation of
drug, template, and enzyme before the onset of RNA synthesis is reduced.

In the view of the probability and kinetic considerations pre-

sented above, the observation that Miracil D inhibits initiation of RNA
synthesis at r values greater than 0.05 (see section III.5.4) seems to
be the result of two factors: (1) the dissociation rate constant of the
Miracil D-DNA complex and (2) the period of incubation (see section
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II.11) of Miracil D, template, and enzyme before the start of RNA
synthesis.
If the only effect of initiation inhibitors is to prevent the
binding of enzyme to the recognition region, then, based on the
considerations above, drugs with low dissociation rates would be the
most likely candidates as inhibitors of initiation.

They could be

viewed as retarding the formation of active enzyme-template complex
simply by occupying the recognition region for extended periods of
time.
The actinomycin family is an example of drugs dissociating from
their complexes with DNA at slow rates (MUller and Crothers, 1968).
Although actinomycin D is principally a strong inhibitor of elongation
(Hyman and Davidson, 1970), it can inhibit

&~A

chain initiation (Maitra

et al., 1967; Sentenac et al., 1968), as mentioned earlier.

Therefore,

in the comparison of the relative effectiveness of different drugs as
inhibitors of initiation of RNA synthesis, both initiation and elongation inhibitors should be considered, since either type of inhibitor can under proper conditions inhibit initiation.

At the present

time, the comparison is not possible due to lack of such information.
In addition, the composition of the recognition region could be a
complicating factor, since actinomycin D binds only to G-C base pairs.
The prevention of enzyme binding to the recognition region by
initiation inhibitors is not the only way drugs can interfere with initiation.

When the active enzyme-template complex is formed, the two

strands of the template are separated by the bound enzyme for a length
of seven or eight base pairs (see above).

Drug molecules bound in the
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vicinity of enzyme-template complex can hinder this strand separation
(melting-in).

In the case of actinomycin binding to DNA, for instance,

it has been found that binding increases the melting temperature of DNA
regions as far as 15 base pairs away from the actual site of binding
(Burd et al., 1975).

This telestabilizing effect could conceivably be

detected by the enzyme, and the rate of melting-in could thus be decreased.
In this simplified overview of the mechanism of inhibition of
initiation of RNA synthesis, both the binding and the melting-in steps
can be interfered with by inhibitors.

The present experimental data

concerning the initiation inhibition of RNA synthesis by Miracil D (see
section III.5.4) are not adequate to arrive at a firm conclusion
whether Miracil D interferes with the binding or the melting-in (or
both) steps of initiation.
Methyl-Miracil D also inhibits RNA synthesis (see section
111.5.3).

If the intrinsic association constant estimated (see section

111.5.3) is essentially correct, then this derivative, when bound to
DNA, is as effective an inhibitor of
Miracil D.

~~A

synthesis as is DNA-bound

Based on the similarity of the dependence of the reciprocal

initial velocity on the binding ratio for both Miracil D and its methyl
derivative (Figure 40), the inhibition of both elongation and initiation is probable for the latter as well, although the inhibition of
initiation by methyl-Hiracil D was not investigated separately.
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IV.5.2.
and

The Inhibition of Elongation of RNA Synthesis by.Miracil D

Methyl~iracil

D

In order to explain the relative inhibitory effectiveness of
actinomycins as inhibitors of RNA chain elongation, it was proposed
that this effectiveness is related also to their dissociation rate
constants from the drug-template complex (MUller and Crothers, 1968).
According to these authors, as the enzyme moves along the DNA template
in the course of transcription, the enzyme will encounter intercalated
drug molecules.

As a result, RNA synthesis comes to a halt, and the

enzyme must wait until the drug dissociates or the enzyme forces the
drug molecule to dissociate.
RNA synthesis can resume.

As the next base pair is free of drug,

A good correspondence was obtained, when

using different synthetic and natural templates, between the relative
effectiveness of actinomycin D to inhibit elongation and the respective
dissociation rate constants.
However, there are difficulties in extending the above proposal
to every inhibitor of IDiA synthesis.

Specifically, if we assume an

average chain growth rate of 2.9 nucleotides/sec (Kozlov, 1971) (representing the incorporation of one nucleotide in 0.34 sec), drug-DNA
complexes with a half-life much shorter than 0.34 sec would not be expected to appreciably inhibit RNA chain elongation.

For ethidium

bromide-calf thymus DNA complexes, a dissociation rate of 138 sec-l
has been determined (Bresloff and Crothers, 1975), which suggests a
half-life of 0.005 sec (=log 2/138).
e

This half-life is then about 68

times shorter than the average incorporation time of one nucleotide.
Accordingly, ethidium bromide would not be expected to inhibit

&~A

chain
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elongation.

Contrary to expectation, however, it was found that

ethidium bromide does inhibit elongation by about 50 % of those

P~A

molecules whose initiation has not been blocked (Richardson, 1973).
To reconcile this discrepancy, the mechanism of
longation should be considered.

&~A

chain e-

In the active enzyme-template complex,

the two strands of the template are separated for a length of seven or
eight base pairs (see above).

In the course of transcription, the

enzyme continuously separates the two strands of the template in the
direction of RNA chain growth, and subsequently the separated strands
reform the double helix as the enzyme moves past them.

Due to tele-

stabilization of DNA by drugs (see above), it appears that this continuous strand separation can be retarded by drug molecules bound to
DNA many sites away from the actual site of RNA synthesis.

Conse-

quently, in order for the enzyme to elongate RNA chains uninhibited, it
seems that a long stretch of base pairs must be free of drug in the direction of

Rl~A

chain growth.

At higher binding ratios, this is equiva-

lent to the simultaneous dissociation of a number of inhibitor molecules from the complex within a region of several base pairs extending
in front of the enzyme.

Therefore, if telestabilization plays an

active role in the inhibition of elongation, the half-life of drug-DNA
complexes may not be an appropriate measure for judging the expected
effectiveness of inhibition.

Rather the simultaneous half-life of many

complexes should be considered.

However, no experimental data are

available on the telestabilization of DNA by ethidium bromide and
a calculation of an appropriately combined half-life for several
complexes would be an extremely complicated task.

Therefore, a more
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specific explanation as to why ethidium bromide inhibits elongation
inspite of the short half-life in the ethidium bromide-template complex
(discussed above) cannot be offered at the present time.
The stabilization of DNA in the. presence of }Uracil D and
methyl-Miracil D noted from hyperchromicity studies of both of these
complexes (see section III.4.3) indicates that these drugs increase the
resistance of DNA against heat denaturation.

Since RNA polymerase con-

tinuously separates the two strands of DNA in the course of chain elongation, the inhibitory action of the bound forms of the two drugs
toward

Rl~A

chain elongation (see section III.5.3) should parallel their

effectiveness in stabilizing template DNA (see section III.4.3).
Indeed, Miracil D and methyl-Miracil D, when bound to DNA, are equally
effective in stabilizing DNA against heat denaturation (see section
III.4.3) and equally effective in inhibiting

~1A

polymerase (see

section III.5.3).
IV.6.

Considerations on the

~ssociation

Miracil D, Methyl-Miracil D, and

and Dissociation Rates of

MD~IT

As a result of binding to the DNA template, both Miracil D and
its methyl derivative inhibit

~~A

synthesis.

Since they are equally

effective inhibitors of RNA chain elongation, they may be expected to
have similar dissociation rate constants from their complexes with DNA
(see previous section).

It may be recalled that the intrinsic associ-

ation constant K of Miracil D with DNA is larger than that of the
methyl-Miracil D (see sections III. 2.1 and III. 2.4, respectively).
Also, the intrinsic association constant K for any binary complex
is related to the association rate constant k

ass

and to the dissoci-
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ation rate constant kdiss through the equation

kass

K=------- .
kdiss
Therefore, it would appear that

~1iracil

D associates with DNA faster

than methyl-Miracil D, i.e. kass,MD > kass,MMD •

Consequently, methyl-

Miracil D would be expected to have a greater activation energy for association with DNA than Hiracil D.

This seems to be a reasonable

expectation based at least on inspection of the CPK models for the
Miracil D-DNA complex relative to that of the

methyl~iracil

D-DNA

complex (see section IV.3), which suggests that formation of the latter
complex may require higher activation energy.
From the present binding studies it also appears that 1-(4methyl-1,4-diazapentyl)-4-methyl-10-thioxanthene (abbreviated as MDMT)
has a smaller intrinsic association constant
binding constant) than that

III.2.5).

(~)

~1DMT

(i.e. equilibrium

of methyl-Hiracil D (see section

On the basis of the relative magnitudes of these intrinsic

association constants (i.e. equilibrium binding constants), the following relationship holds:

or

KMMD
kass,MMD

>

KMDMI'
kass,MDMT

----------- > ------------

kdiss,MMD

kdiss,MDMT

The results presented in Figure 38 indicate that MDMT and methylMiracil D inhibit RNA polymerase roughly to the same extent when compared on the basis of total inhibitor concentration present in the as-
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say solutions.

Since MDMT has a smaller intrinsic association constant

than methyl-Miracil D, it follows that MDMT, if it were compared on the
basis of drug-DNA binding ratios as it should, would have been found to
be a stronger inhibitor of RNA synthesis than methyl-Miracil D.

Based

on considerations cited in the preceding section, MDMT should,
therefore, have a lower dissociation rate constant than that of methylMiracil D, i.e. k

diss,MDMT

< k

diss,MMD

k

kdiss,MDMT

Consequently,

diss,MMD

From the two unequalities of association to dissociation rates, it
follows that

kd.J.ss,MMD

k

diss,MMD

After multiplying by kdiss,MMD' the relationship kass,MMD > kass,MDMT
is obtained, indicating that methyl-Miracil D associates with DNA
faster than MDMT.
It is not known at this time whether the formation of the MDMTDNA complex is accomplished by intercalation of the MDMT molecule.

If

intercalation is involved, this process would require very high activation energy, since the MDMT molecule is not planar (see section 1.2)
and intercalation, similar to that of Miracil D with DNA, would require
that the MDMT molecule become planar.

Such a mechanism of complete

intercalation would, therefore, be compatible with the small association rate constant predicted above from the results of binding and
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inhibition studies.
A completely intercalated MDMT-DNA complex, however, would be expected in analogy to Miracil D and

methyl~iracil

D (see sections

111.3.1 and 11!.3.2, respectively) to exhibit optical activity.
Although no optical activity was observed experimentally in the case of
MD~IT-DNA

complexes (see section 111.3.3), the existence of optical ac-

tivity for MDMT-DNA complexes cannot be ruled out for the reasons enumerated in section 1!!.3.3.
The possibility that partial intercalation of the MDMT molecule
occurs by means of one of the benzene rings should also be considered,
but such a mechanism of intercalation appears to be inconsistent with
the slow association rate with DNA predicted above.
pletely intercalated

MDMT-D~A

Therefore, a com-

complex is proposed, in which the non-

planar MDMT molecule becomes planar as the result of intercalation between adjacent base pairs of the DNA double helix.
models concerning the structure of

MDMT-D~A

Of course, other

complex cannot.on the ba-

sis of the present data be ruled out.
In summary, the follol'Ting relationships among the intrinsic association constants (K) and the association and dissociation rate
constants (k) for

~Uracil

D, methyl-Miracil D, and MDMT are consistent

with the molecular structure of these compounds and with the results of
the present binding and inhibition studies:
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k

ass ,ND

k.

d1ss ,MD

>
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In

conclusion~

calf thymus

D~A

the binding of Miracil D and methyl-Miracil D to

was studied by two spectrophotometric methods.

Both

drugs were found to conform to a model in which two adjacent binding
sites cannot be occupied simultaneously.

It has also been shown that

Miracil D has a greater affinity to native DNA than methyl-Miracil D.
However, when bound to DNA, both drugs are equally effective in stabilizing DNA against heat denaturation and inhibiting DNA dependent RNA
synthesis.

CHAPTER V
SUMMARY

Miracil D, a schistosomicidal, carcinostatic, and bacteriostatic
compound is known to bind to DNA through intercalation.

In the re-

sulting complex, the planar heterocyclic ring system of the drug is inserted between adjacent base pairs of the DNA helix, and the positive
diethylaminoethylamino side chain of the drug interacts with the negative phosphate backbone of DNA.

The circular dichroism measurements in

this work suggest that, as a result of the binding, the conformation of
the neighbouring binding sites in DNA is also modified.

Such a confor-

mational change may prevent the binding of drug molecules to sites
which are adjacent to occupied sites.

Consequently, when the exclusion

in binding to the nearest neighbour sites is taken into account, an intrinsic association constant of 1.2x10 6 M-l is obtained in 0.01 M sodium acetate buffer, pH 5.0 and at 25 °C.

We have found that this in~

trinsic association constant substantially decreases with increasing
temperature and ionic strength.
In the case of

methyl~iracil

D, the intrinsic association

constant (1.7xl0 5 M- 1) is lower than that of the binding of Miracil D
to DNA.

In the former derivative, in contrast to Miracil D, the proxi-

mal -NR 2 grouping is reported to be non-coplanar with the heterocyclic
ring system due to steric interference.
mal nitrogen atom of

methyl~iracil

The conformation of the proxi-

D may thus limit the depth of drug

penetration between the base pairs of the DNA double helix, and may,
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therefore, reduce the electrostatic interaction between the positive
side chain of the drug and the negative phosphate backbone of DNA.
Both Miracil D and

methyl-~Uracil

become active when bound to DNA.

D are optically inactive but

The circular dichroism bands of

Miracil D-DNA and methyl-Miracil D-DNA complexes are located at the
absorption maxima and shoulders in the spectra of the bound drugs.
differential molar extinction coefficients of

~1iracil

The

D-DNA complexes

at 337, 347, and 447 nm and of methyl-Miracil D-DNA complexes at 335,
353, and 405 nm decrease as the binding ratio (the ratio of the bound
drug concentration to the DNA concentration) increases, indic.ating that
the conformational changes in DNA, due to binding, extend to sites beyond the nearest neighbour binding sites.

Based on the non-conserva-

tive character of the observed circular dichroism bands, it is suggested that the induced optical activity is the result of the interaction between these drugs and the asymmetric binding sites of DNA.
Miracil D and methyl-Miracil D stabilize DNA against heat denaturation as measured by the increase of the mid-transition temperature of drug-DNA complexes relative to that of native DNA.

The drugs

are equally effective in this respect when the comparison is made on
the basis of binding ratios prevailing at the mid-transition temperature of the complexes.

At low binding ratios, the reintercalation of

Miracil D in the course of thermal denaturation of DNA is observed, as
evidenced from circular dichroism measurements.
Both Miracil D and

methyl~iracil

D inhibit DNA dependent RNA

polymerase by inactivating the DNA template as a result of drug
binding.

These intercalators are equally effective in this respect
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when the comparison is made at equal binding ratios of drug-DNA
complexes.

Furthermore, below a binding ratio of 0.05, Miracil D in-

hibits only the elongation step of RNA synthesis, and the reciprocal
initial velocity of elongation is linearly proportional to the binding
ratio of the Miracil D-DNA complex.
0.05, however, the initiation of

At binding ratios greater than

&~A

equal effectiveness of Miracil D and

chains is inhibited as well.
methyl~iracil

The

D in inhibiting RNA

chain elongation and in stabilizing DNA against heat denaturation suggests that these drugs inhibit

P~~A

polymerase by retarding the strand

separation of the DNA template in the course of RNA chain elongation.
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APPENDIX A
A Proposed Model for the Structure of Miracil D Dimers
in Aquaeous Media
Dyes, which are generally derivatives of planar heterocyclic
aromatic rings, have long been known to form molecular aggregates in
aquaeous solutions (Rabinowitch and Epstein, 1941).

Aggregation is

generally accompanied by spectral changes and under certain circumstances these spectral changes can be used to quantitate the aggregation process.

The molecules in the aggregates are placed with their

planes parallel to one another like coins in a stack.

The aggregate

is stabilized by dipole-dipole, dipole-induced dipole interactions and
London dispersion forces.

Charges located within the molecules gener-

ally can destabilize the aggregate.
For Miracil D, a stacked dimer structure can also be postulated
which produces maximum stabilization by dispersion forces.

Four major

"stacked" arrangements are possible in which the long molecular axes
are parallel to one another.

Only two out of these four arrangements

place the molecular dipoles in an opposing arrangement favourable for
dipole-dipole interactions.

In order to obtain maximum separation of

the positive charges carried on the diethylaminoethylamino side chain
of the Miracil D molecule, which could destabilize the dimer, the dimer
with diagonally located side chains should be considered as the most
probable structure for Miracil D dimers in 0.01 and 0.2 M sodium
acetate buffers, pH 5.0 (Figure 42).
190
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Figure 42.
solutions.

A dimer structure proposed for Miracil D in aquaeous
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The experimental results obtained in these studies are consistent with the postulated dimer structure in two respects.

First,

the positively charged side chains are placed at a distance in the
dimer that reduces the electrostatic repulsion between them to a negligible level.

Therefore, changes in the ionic strength should not be

expected to influence the stability of the dimer as a result of
shielding of the electric charges.

Indeed, the experimentally de-

termined dimerization constants in 0.01 and 0.2 M sodium acetate
buffers, pH 5.0 are found to be independent of ionic strength (see
section 111.1).

Secondly, it may be noted that upon dimerization, the

monomeric form of Miracil D is transferred from a completely aquaeous
environment to an environment in which only one face of the molecule is
exposed to the aquaeous phase while the other face being placed into
contact with a hydrophobic medium.

This environmental change is ac-

companied by a red shift of the absorption peak at 330 nm as expected.
A similar red shift in this absorption maximum of Miracil D is observed
upon transfer of the drug from polar to non-polar solvents (Zilversmit,
1971).
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APPENDIX B
The Calculation of the Binding Isotherm
for the Exclusion Model
For the calculation of the binding isotherms of the exclusion
model, a computer program was used, written in CPS PL/I language.

The

program is shown below:
GET LIST(N);
DECLARE A(N) CONTROLLED ,DNA(N) CONTROLLED ,R(N)
CONTROLLED ,ROCF(N) CONTROLLED ,AC(N) CONTROLLED;
IF ALLOCA(A) THEN FREE A,DNA,R,ROCF,AC;
3.
4.
-ALLOCATE A,DNA,R,ROCF,AC;
5.
GET LIST(A,DNA,CT);
6.
GET LIST(AF,AB);
NEWK:
GET LIST(K);
7.
PUT
LIST('ASSOCIATION CONSTANT
8.
=' ,K) ;
PUT LIST('ABSORBANCE OF FREE DRUG
9.
=' ,AF);
PUT LIST('ABSORa~CE OF BOUND DRUG
=',AB);
10.
11.
PUT LIST('TOTAL DRUG CONCENTRATION
=' ,CT);
DO I=2 TO N;
12.
13.
R(I)=(AF-A(I))*CT/(AF-AB)/DNA(I);
ROCF(I)=(AF-A(I))/(A(I)-AB)/DNA(I);
14.
END;
15.
16.
I** I;
DO I=2 TO N;
17.
CALL CALCA(K,CT,DNA(I),AF,AB,X);
18.
AC(I)=X;
19.
END;
20.
DO I=2 TON;
21.
PUT LIST ( ' ' ) ;
22.
PUT LIST (' ') ;
23.
PUT LIST('
SAMPLE II' , I) ;
24.
PUT LIST ( ' ') ;
25.
CALL CALCA(K,CT,l.015*DNA(I) ,AF,AB,ACDU);
26.
CALL CALCA(K,CT,.985*DNA(I),AF,AB,ACDL);
27.
PUT LIST('LOWER ABS. LI:HIT
=' ,ACDU-.003);
28.
PUT LIST('UPPER ABS. LIMIT
=' ,ACDL+.003);
29.
=',A(I));
PUt LIST('ABSORBANCE OBSERVED
30.
. 31.
IF A(I)>ACDU-.003&A(I)<ACDL+.003 THEN PUT LIST ('
IN RAl~GE'); ELSE PUT LIST('
NOT
IN RANGE');
1.

z.
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32.
PUT LIST('R OBSERVED
=' ,R(I));
33.
PUT LIST( 'R/CF OBSERVED
=' ,ROCF(I));
34.
PUT LIST('R THEORETICAL
='~(AF-AC(I))*CT
/(AF-AB)/DNA(I));
35.
PUT LIST('R MAX. DUE TO ERROR
='~(AF-ACDU+.003)*
CT/(AF-AB)/DNA(I));
36.
PUT LIST ( 'R MIN. DUE TO ERROR
~',(AF-ACDL-.003)*
CT/(AF-AB)/DNA(I));
37.
PUT LIST('R/CF THEORETICAL
=' '(AF-AC(I)) I
(AC(I)-AB)/DNA(I));
38.
PUT LIST('R/CF MAX. DUE TO ERROR ='~(AF-ACDU+.003)/
(ACDU-.003-AB)/DNA(I));
39.
PUT LIST('R/CF MIN. DUE TO ERROR =' ~(AF-ACDL-.003)/
(ACDL+.003-AB)/DNA(I));
40.
PUT LIST('EXP. DNA CONC.
=' ,DNA(I));
41.
END;
42.
CALCA: PROCEDURE (KP ,CTP ,DNAP ,AFP ,ABP ~AP);
43.
ALPHA=(-16*KP*CTP-8*KP*DNAP-4)/16/KP/DNAP;
44.
BETA=(8*KP*CTP+KP*DNAP+2)/16/KP/DNAP;
45.
GAMMA=-cTP/16/DNAP;
46.
IF BETA<3/16 THEN RUP=4*BETA/3; ELSE RUP=.25;
RLP=O;
47.
48.
COUNT=l;
49.
HALF:
RP=.5*(RLP+RUP);
50.
D=RP** 3+ALPHA*RP**2+BETA*RP+GAMMA;
51.
IF D=O THEN GO TO EXIT;
52.
IF D>O THEN RUP=RP;
53.
IF D<O THEN RLP=RP;
54.
IF COUNT>30 THEN GO TO EXIT;
55.
COUNT=COUNT+l;
56.
GO TO HALF;
57.
EXIT:
AP=AFP-(AFP-ABP)*RP*DNAP/CTP;
58.
END CALCA;
59.
STOP;
Storage area for the

~~perimental

data and the calculated

quantities of N samples is allocated in instructions 1 through 4.

Ab-

sorbances (A), nucleic acid concentrations (DNA), total drug concentration (CT), absorbances of free (AF) and bound (AB) drug are requested in instructions 5 and 6.

The experimental values of r (R) and

r/cf (ROCF) of the samples are calculated in instructions 12 through
15.

The theoretical absorbance (AC) of the samples with the arbi-

trary association constant (K), which is requested in instruction 7,
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are calculated in instructions 17 through 20 using the in.ternal procedure CALCA.

The theoretical absorbance is calculated on the basis

of the actual nucleic acid concentration.

An error of 1.5 % in nucleic

acid concentration is assumed, and the absorbances (ACDU and ACDL)
corresponding to 1.5 % and -1.5 % errors are calculated in instructions
26 and 27.
Since the error of absorbance measurements is superimposed on
the error in nucleic acid concentrations, an error of 0.003 in absorbance is taken into account at this point (ACDU-0.003 and ACDL+0.003).
If the experimental absorbance falls between these two limits, IN RANGE
is printed in instruction 31.

The values of r and r/cf corresponding

to these absorbance limits and to the theoretical absobance are calculated in instructions 34 through 39.
The internal procedure CALCA consists of instructions 42 through
58.

This procedure calculates the zero place of a polynomial of third

degree in the 0 < RP < 0. 25 range.

The notation of variables is the

same as those in Appendix C, except that P's are added to the end of
the variable names (in instructions 42 through 58) to signify that they
are used in the internal procedure CALCA.
In the approximation of the zero place, the method of interval
bisection is used.

According to this method, the interval, in which

the zero place is located, is halved and that half is selected as the
basis of the next approximation step, for which the polynomial at the
endpoints of the selected interval has opposite signs.

The halving is

repeated 30 times, so that the value of RP is determined with an accuracy of at least 0.25/2 30=2.3x1o- 10 .

The analytical form of the poly-
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nomial, and the existence and uniqueness of the zero place in the
[0,0.25] interval are discussed in Appendix C.
Different values of K can be examined as to whether they fit the
experimental points within experimental error or not by executing instructions 7 through 59.

APPENDIX C

199

APPENDIX C
Mathematical Proof for the Existence and Uniqueness of the Solution
of Binding Isotherm for the Exclusion Model
The binding of ligands to nucleic acids, when binding to the
nearest neighbour sites is not allowed, can be described by equation

r

(l-4•r) 2

----=K·----------cf
2•(1-2•r)

(4)

where the binding ratio r is defined as

cb

r=---- '

(3)

(P]

and cf and cb are the molar concentrations of free and bound ligands,
K is the intrinsic association constant, and [P] is the nucleic acid
concentration (McGhee and von Hippel, 1974).

Since for the total drug

concentration ct we have

using the definition of the binding ratio r, cf can be expressed as

Substitution of cf into equation (4) produces the following relationship:
200
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(l-4•r) 2

r

----------=K·----------.
c -r·[P]
2·(1-2·r)
t

By defining a, e, andy as

_______
__________ _
16·K·ct +8·K·[P]+4
a=-

,

16·K·[P]
8·K•c +K·[P]+2

s=------t----.----- ,

and

16·K•[P]

c
y=- ----~--16·[P]

the binding isotherm can be written as a cubic equation of the form

3
2
r +a·r +s•r+y=O.
In the interpretation of binding studies on the basis of this exclusion
model, it is necessary to determine the value of r for given sets of
K, ct, and [P].

Since the calculation of the roots of this cubic e-

quation by the Cardano formula is complex, a straightforward numerical
approximation was developed.

For the successful application of this

numerical approximation, it was necessary to analyze the cubic equation
itself.
Defining the f(r) polynomial by
f(r)=r 3+a•r 2+e·r+y ,
solving the cubic equation is equivalent to finding the zero places of
the f(r) polynomial.

< <

Since only those r values, for which O=r=0.25,
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have real physical meaning, solutions may be restricted to the
[0,0.25] interval.

At the endpoints of this interval f(O)=-c /(16•[P])
t

and f(0.25)=1/(64·K·[P]).

The values of c , K, and [P] are positive
t

numbers, therefore, f(O)<O and £(0.25)>0, i.e. the f(r) polynomial
changes sign in the [0,0.25] interval.

The f(r) polynomial is con-

tinuous for any r and, according to Bolzano's theorem, an r for which
f(r)=O, where O<r<0.25, should exist.

This assures that the f(r)

polynomial has at least one zero place in the interval of interest.
That there is no more than one zero place will be proven below.
For this purpose, three cases will be distinguished on the basis of the
value of S·

The value of S determines whether the local extrema are

maxima or minima.

(The apostrophe will denote differentiation with

respect to r.)
Case 1: 8>3/16
Since f'(0.25)=0 and f' '(0.25)=-4·8+3/4<0, the polynomial exhibits a
local maximum at r=0.25.

Since f'(4·8/3)=0 and f''(4•8/3)=4·S-3/4>0,

the f(r) polynomial exhibits a local minimum at r=4·S/3>0.25.

These

extrema are separated by an inflection point at r=2·B/3+1/8>0.25.
Since f'(r)=3·(1-4·r)•(4·S/3-r)/4, and each term is positive if r<0.25,
then f'(r)>O if r<0.25.
[0,0.25] interval.

Therefore, f(r) is monoton increasing in the

Hence f(r) cannot have more than one zero place in

the interval of interest (Figure 43, curve 1).
Case 2: s=3/16
The f(r) polynomial has no local extrema but exhibits an inflection
point at r=0.25 because £''(0.25)=0.

2
Since f'(r)=3·(1-4·r) /16>0 for

any r, f(r) is monoton increasing for any r.

Hence f(r) cannot have
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Figure 43.

Schematic representation of the f(r) polynomial for

different values of 8 as parameter.
8<3/16 (see text for details).

(1) 8>3/16, (2) 8=3/16, and (3)
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i(r)

0.25

r
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more than one zero place in the [0,0.25] interval (Figure 43, curve 2).
Case 3: 8<3/16
Since f'(4•8/3)=0 and f''(4•8/3)=4·8-3/4<0, the f(r) polynomial exhibits a local maximum at r=4•8/3<0.25.

Since f'(0.25)=0 and

f''(0.25)=-4•8+3/4>0, the f(r) polynomial exhibits a local minimum at
r=0.25.

At this local minimum the polynomial is still positive because

f(0.25)=1/(64•K•[P]).

The extrema are separated by an inflection

point at r=2•8/3+1/8<0.25.

Since f'(r)=3•(1-4•r)•(4·B/3-r)/4, the f(r)

polynomial is moncton increasing when r<4•S/3 (before the local maximum), is monoton decreasing when 4·S/3<r<0.25 (between the two extrema), and is moncton increasing again when r>0.25 (after the local
minimum).

Consequently, there is only one zero place in the [0,4•8/3]

interval.

Although f(r) is monoton decreasing in the [4•8/3,0.25]

interval, there is no zero place in this interval because the polynomial is still positive at the minimum.

Hence there is only one zero

place in the [0,0.25] interval (Figure 43, curve 3).
It can be concluded that there is one and only one zero place
in the [0,0.25] interval regardless of the value of

s.
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